{"gene":"ATP2B2","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":1992,"finding":"The human ATP2B2 gene was isolated and characterized, encoding a plasma membrane Ca2+-pumping ATPase isoform PMCA2. Human and rat cDNA sequences showed 95% homology in the coding domain and >98% homology at the deduced protein sequence level. The gene was localized to human chromosome 3.","method":"cDNA cloning, sequencing, somatic cell hybrid Southern blot analysis","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 1 — original molecular characterization with cDNA cloning and sequencing","pmids":["1427863"],"is_preprint":false},{"year":1993,"finding":"PMCA2 undergoes alternative splicing at two major regulatory sites (site A in the first intracellular loop and site C in the C-terminal calmodulin-binding domain), generating multiple isoforms. PMCA2 and PMCA3 transcripts are expressed in a tissue-specific manner, with highest levels in fetal skeletal muscle and brain, in contrast to the ubiquitous PMCA1 and PMCA4.","method":"Quantitative RT-PCR with isoform-specific primers across seven human tissues","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — quantitative molecular analysis across multiple tissues with isoform-specific detection","pmids":["8245032"],"is_preprint":false},{"year":1994,"finding":"ATP2B2 (PMCA2) was localized to human chromosome 3p26→p25 by fluorescence in situ hybridization (FISH), analysis of somatic cell hybrids, and genetic linkage analyses.","method":"FISH, somatic cell hybrid analysis, genetic linkage","journal":"Cytogenetics and cell genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal mapping methods","pmids":["8187550"],"is_preprint":false},{"year":2001,"finding":"The PMCA2b C-terminal tail interacts with multiple members of the membrane-associated guanylate kinase (MAGUK)/SAP family, including SAP90/PSD95, PSD93/chapsyn-110, and SAP97, but not SAP102, whereas PMCA4b interacts promiscuously with all four SAPs. PMCA2b colocalized with SAP90/PSD95 in hippocampal neuron dendrites and dendritic spines.","method":"Yeast two-hybrid screen, co-immunoprecipitation, confocal immunofluorescence microscopy in polarized MDCK cells and hippocampal neurons","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP and localization with functional context, multiple methods","pmids":["11274188"],"is_preprint":false},{"year":2001,"finding":"PMCA2 is expressed in the P-type ATPase family characterized by formation of an aspartyl-phosphate intermediate during the reaction cycle. Alternative splicing of PMCA2 at the first intracellular loop (site A) and C-terminal tail (site C) generates isoforms with different calmodulin regulation, phospholipid sensitivity, and PDZ-domain protein interactions. The PMCA2w/a splice variant is the major form in hair cell stereocilia.","method":"Biochemical characterization, review of splice variant expression and functional differences","journal":"Physiological reviews","confidence":"High","confidence_rationale":"Tier 1 — comprehensive review integrating multiple independent biochemical and genetic studies","pmids":["11152753"],"is_preprint":false},{"year":2004,"finding":"PMCA2 is localized to hair cell stereocilia in mouse inner ear (demonstrated by immunocytochemistry), where it contributes to maintaining endolymph calcium homeostasis. Deafwaddler2J (dfw2J) mice lacking functional PMCA2 in stereocilia have significantly lower endolymph calcium concentrations compared to controls, linking PMCA2 stereociliary activity to endolymph Ca2+ levels and hearing/balance function.","method":"Immunocytochemistry, calcium-sensitive fluorescent dye measurement using aspirating microelectrode in dfw2J vs. control mouse endolymph","journal":"Journal of the Association for Research in Otolaryngology : JARO","confidence":"High","confidence_rationale":"Tier 2 — direct localization with functional consequence measured by calcium assay in loss-of-function model","pmids":["15357414"],"is_preprint":false},{"year":2005,"finding":"A heterozygous, hypofunctional variant (V586M) in PMCA2 (ATP2B2) acts as a modifier of sensorineural hearing loss severity. In siblings homozygous for a CDH23 mutation, those also carrying V586M had more severe hearing loss. V586M was also found in unrelated individuals with increased hearing loss caused by other factors (MYO6 mutation or noise exposure), establishing PMCA2 as a genetic modifier of hearing loss severity.","method":"Genetic analysis of human families with SNHL, functional characterization of V586M as hypofunctional variant","journal":"The New England journal of medicine","confidence":"High","confidence_rationale":"Tier 2 — human genetic epistasis in multiple families with functional variant characterization","pmids":["15829536"],"is_preprint":false},{"year":2006,"finding":"Differential membrane targeting of PMCA1 and PMCA2 in hair cells is determined by distinct molecular signals: a Leu-Ile motif in 'b'-tail splice variants promotes basolateral sorting of PMCA1b and PMCA2b, while apical targeting of PMCA2 depends on the size of the A-site splice insert in the first cytosolic loop, suggesting the loop conformation plays a role in apical targeting.","method":"Expression of PMCA isoforms and splice variants with mutagenesis in hair cells and cell lines, immunofluorescence targeting assays","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — mutagenesis-guided localization studies in native hair cells identifying specific targeting determinants","pmids":["16803870"],"is_preprint":false},{"year":2006,"finding":"PMCA2 co-immunoprecipitates with the metabotropic glutamate receptor 1 (mGluR1), Homer 3, and IP3R1 in the cerebellum, indicating that PMCA2 is a constituent of the mGluR1 signaling complex. In PMCA2-null mice, the levels of mGluR1, IP3R1, Homer 1b/c, and Homer 3 are specifically reduced in Purkinje neurons but not in hippocampus, perturbing the mGluR1 signaling complex and likely contributing to cerebellar deficits.","method":"Co-immunoprecipitation, immunohistochemistry, Western blotting in PMCA2-null vs. wild-type mouse cerebellum","journal":"Molecular and cellular neurosciences","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP identifying complex membership, confirmed by loss-of-function phenotype","pmids":["17150372"],"is_preprint":false},{"year":2006,"finding":"Atp2b2 expression is regulated through four distinct transcriptional start regions (alpha, beta, mu, delta) with tissue-specific usage. The alpha transcript is dominant in cochlear hair cells and cerebellar Purkinje neurons, while mu and delta are novel variants expressed predominantly in lactating mammary gland. The alpha and beta first-exon regions show high conservation in mammals.","method":"5'-RACE, real-time RT-PCR, microdissection of cochlea, in situ hybridization, comparative genomics","journal":"Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods identifying tissue-specific regulatory mechanisms","pmids":["16675132"],"is_preprint":false},{"year":2008,"finding":"The Oblivion (Obl) ENU-induced mouse mutation causes a S877F substitution in transmembrane domain 6 of PMCA2. Unlike other transmembrane domain mutations, the protein is correctly targeted to the plasma membrane, but biochemical and biophysical characterization showed significant loss of non-stimulated Ca2+ exporting ability, explaining progressive hearing loss.","method":"ENU mutagenesis, sequencing, immunofluorescence of mutant pump in hair cells, biochemical/biophysical characterization of Ca2+ export in CHO model cells","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1-2 — biochemical activity assay and localization of mutant pump with clear phenotypic correlation","pmids":["18974863"],"is_preprint":false},{"year":2010,"finding":"The Tommy ENU mutation (E629K in the second intracellular loop/active site) impairs long-term, non-stimulated calcium extrusion activity of PMCA2 in CHO cells. Direct calcium imaging with flash photolysis of caged calcium in neonatal organotypic utricle cultures confirmed impairment of calcium export in both Tommy heterozygotes and homozygotes, establishing that cytosolic calcium clearance in hair cells requires PMCA2 active-site integrity.","method":"Ca2+ extrusion assay in CHO cells expressing mutant PMCA2, confocal imaging with flash photolysis of caged Ca2+ in utricle sensory epithelium organotypic cultures","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct functional assay in both heterologous cells and native tissue with well-defined mutant","pmids":["20826782"],"is_preprint":false},{"year":2010,"finding":"PMCA2 is the dominant mechanism for Ca2+ clearance in cerebellar Purkinje neuron dendrites. Heterozygous PMCA2 knockout mice expressing half-normal PMCA2 levels showed nearly doubled calcium transient recovery times, weaker climbing fiber responses, prolonged Ca2+-dependent K+ currents, and reduced action potential firing frequency, demonstrating that PMCA2 level directly controls dendritic calcium dynamics and cerebellar motor coordination precision.","method":"Calcium imaging in brain slices, whole-cell patch clamp recording, beam-walking motor tests in PMCA2+/- vs. wild-type mice","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 — clean haploinsufficiency model with defined electrophysiological and calcium phenotypes, multiple orthogonal methods","pmids":["20083513"],"is_preprint":false},{"year":2010,"finding":"PMCA2 is down-regulated early during mammary gland involution following weaning, and this loss raises intracellular calcium and sensitizes mammary epithelial cells (MECs) to apoptosis. Conversely, overexpression of PMCA2 in T47D breast cancer cells lowers intracellular calcium and protects them from apoptosis, identifying PMCA2 as a calcium extrusion pump that regulates apoptotic threshold in MECs.","method":"Western blotting, calcium imaging, apoptosis assays in PMCA2 knockdown/overexpression MECs and T47D cells, mammary gland involution model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — loss and gain of function with defined calcium and apoptosis readouts","pmids":["20534448"],"is_preprint":false},{"year":2010,"finding":"In PMCA2-/- Purkinje neurons, basal calcium levels are elevated, calcium recovery kinetics are severely impaired, membrane potentials are hyperpolarized, spontaneous action potential frequency is reduced and irregular, complex spikes are curtailed, and Ca2+-dependent outward K+ currents are sustained. These electrophysiological changes represent adaptations that limit pathological calcium rises but are insufficient to maintain normal cerebellar output.","method":"Whole-cell patch clamp recording and calcium imaging in PMCA2-/- vs. wild-type Purkinje neurons","journal":"Functional neurology","confidence":"High","confidence_rationale":"Tier 2 — direct electrophysiological and calcium measurements in knockout Purkinje neurons","pmids":["21232211"],"is_preprint":false},{"year":2011,"finding":"Analysis of the human PMCA2 V586M mutant (associated with modified hearing loss in patients) and a murine mutant in model cells revealed that the human mutant does not impair Ca2+ ejection by the pump, whereas the murine mutant shows defects in both basal pump activity and long-range Ca2+ ejection. The PMCA2w/a splice variant can eject Ca2+ to the endolymph even in the absence of calmodulin, satisfying the special Ca2+ homeostasis requirements of stereocilia.","method":"Expression of mutant PMCA2 in model cells, Ca2+ ejection assays, comparison of human and murine mutants","journal":"Cell calcium","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro Ca2+ extrusion assay with defined mutants and calmodulin-independence characterization","pmids":["22047666"],"is_preprint":false},{"year":2012,"finding":"PMCA2 inhibits the calcineurin/NFAT signaling pathway in breast cancer cells through a direct inhibitory interaction with calcineurin. Disruption of the PMCA2/calcineurin interaction activates calcineurin/NFAT signaling, upregulates pro-apoptotic Fas Ligand expression, reduces cell viability through increased apoptosis, and enhances paclitaxel-mediated cytotoxicity.","method":"Co-immunoprecipitation, calcineurin/NFAT pathway activation assays, Fas Ligand expression, apoptosis assays, viability assays in multiple breast cancer cell lines","journal":"Carcinogenesis","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP plus functional pathway activation and apoptosis readouts in multiple cell lines","pmids":["22962307"],"is_preprint":false},{"year":2012,"finding":"PMCA2 is associated with α7-nicotinic acetylcholine receptors (α7-nAChRs) in rat brain via the scaffold protein PSD-95. PMCA2 activity limits the duration of calcium elevations produced by α7-nAChR activation in hippocampal interneurons. PMCA2 inhibition triggers rapid, CaMKII- and proteasome-dependent loss of α7-nAChR clusters through a mechanism that requires PSD-95 linkage and depends on the second intracellular loop of the α7 subunit.","method":"Functional proteomics on rat brain, co-immunoprecipitation, calcium imaging, single-particle tracking, pharmacological inhibition, siRNA knockdown in hippocampal interneuron cultures","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — functional proteomics, co-IP, live-cell calcium imaging, and single-particle tracking with multiple orthogonal methods","pmids":["22593058"],"is_preprint":false},{"year":2012,"finding":"The alternatively spliced w-insert of PMCA2 provides autonomous apical targeting information. When inserted into the corresponding location of the normally basolateral PMCA4 isoform, it confers apical membrane targeting. Optimizing the PDZ ligand at the C-terminus for NHERF2 interaction further enhanced apical targeting. Both apical and basolateral pump configurations handled ATP-induced Ca2+ signals with similar kinetics, indicating the targeting signal does not alter intrinsic pump function.","method":"Chimeric PMCA4(2w)/b construct expression in polarized epithelial cells, immunofluorescence localization, Ca2+ signaling assays, mutagenesis of di-leucine and PDZ ligand motifs","journal":"Cell calcium","confidence":"High","confidence_rationale":"Tier 1-2 — chimeric construct mutagenesis with localization and functional assays identifying autonomous targeting signal","pmids":["22252018"],"is_preprint":false},{"year":2013,"finding":"PMCA2 knockdown in PC12 cells accelerates neuronal differentiation and formation of longer neurites. Loss of PMCA2 triggers apoptosis and DNA laddering during differentiation, accompanied by compensatory upregulation of PMCA1, PMCA4, and SERCA, as well as altered expression of voltage-dependent calcium channels (VDCCs) with increased contribution to Ca2+ influx.","method":"Antisense-mediated stable knockdown in PC12 cells, differentiation assays with dibutyryl-cAMP, apoptosis/DNA laddering assays, immunoblotting for calcium handling proteins, functional VDCC assays","journal":"Cell calcium","confidence":"Medium","confidence_rationale":"Tier 2-3 — loss-of-function with defined cellular phenotypes, single lab","pmids":["22921123"],"is_preprint":false},{"year":2013,"finding":"PMCA2 activity is required for maintaining dendritic calcium equilibrium and controlling Purkinje cell dendritic growth in organotypic cerebellar slice cultures. Pharmacological inhibition of PMCA2 with carboxyeosin moderately reduced Purkinje cell dendritic tree size. Combining PMCA2 inhibition with type I mGluR stimulation partially rescued dendritic morphology by triggering compensatory inactivation of voltage-gated calcium channels.","method":"Carboxyeosin pharmacological inhibition of PMCA2 activity in organotypic cerebellar slice cultures, immunofluorescence, dendritic morphometry","journal":"Neural plasticity","confidence":"Medium","confidence_rationale":"Tier 3 — pharmacological inhibition with morphological readout, single lab","pmids":["24288624"],"is_preprint":false},{"year":2013,"finding":"PMCA2 downregulation by MPP+ (mitochondrial complex I inhibitor) in SH-SY5Y neuroblastoma cells and primary mesencephalic neurons leads to elevated cytosolic calcium and increased neuronal vulnerability. Two other Ca2+ efflux mediators (SERCA, NCX) were unaffected, indicating PMCA2-specific role in neuronal calcium homeostasis. siRNA knockdown of PMCA2 impaired cell survival, while PMCA2 overexpression conferred resistance to complex I inhibition.","method":"MPP+ treatment, Western blotting, calcium imaging, siRNA knockdown and overexpression in SH-SY5Y and primary mesencephalic neurons","journal":"Neurotoxicology","confidence":"Medium","confidence_rationale":"Tier 2-3 — loss and gain of function with calcium and viability readouts, single lab","pmids":["24269647"],"is_preprint":false},{"year":2016,"finding":"PMCA2 interacts with HER2 in actin-rich membrane domains in breast cancer cells. Knocking down PMCA2 raises intracellular calcium, disrupts interactions between HER2 and HSP-90, inhibits HER2 signaling, and causes internalization and degradation of HER2. PMCA2 knockout inhibits mammary tumor formation in MMTV-Neu mice, demonstrating that PMCA2 is required for HER2 membrane retention, stability, and oncogenic signaling.","method":"Co-immunoprecipitation, PMCA2 knockdown and knockout, HER2 signaling assays, subcellular fractionation, intracellular calcium measurement, in vivo MMTV-Neu tumor model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP, multiple loss-of-function approaches, in vivo tumor model, multiple orthogonal methods","pmids":["26729871"],"is_preprint":false},{"year":2017,"finding":"Disrupting the actin cytoskeleton with cytochalasin D significantly increases PMCA2-mediated Ca2+ extrusion (~50-100%) in living HEK293 cells, while stabilizing F-actin with jasplakinolide fully inhibits it. Disrupting microtubules with colchicine decreases PMCA activity (~40-60%). These effects occur without changing surface expression levels, indicating regulation of specific activity.","method":"Real-time cytosolic calcium monitoring in PMCA2-transfected HEK293 cells treated with cytoskeletal drugs, surface biotinylation assays","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"Medium","confidence_rationale":"Tier 2 — functional assay in living cells with pharmacological perturbation of cytoskeleton, surface expression controls","pmids":["28527708"],"is_preprint":false},{"year":2017,"finding":"PMCA2-interacting complex in kidney cells was characterized by immunoprecipitation followed by nanoLC-ESI mass spectrometry, identifying 474 PMCA2-interacting proteins (8 known, 20 predicted, 446 novel). A novel functional role of PMCA2 as a calcium oxalate monohydrate (COM) crystal-binding protein was identified and validated, showing that PMCA2 is required for crystal retention and cellular uptake in kidney cells.","method":"Immunoprecipitation-mass spectrometry, quantitative immuno-co-localization, COM crystal-protein binding assay, crystal-cell adhesion assay, crystal internalization assay, anti-PMCA2 antibody neutralization","journal":"Cellular and molecular life sciences : CMLS","confidence":"Medium","confidence_rationale":"Tier 2-3 — proteomics interactome with functional validation by neutralization antibody","pmids":["29085954"],"is_preprint":false},{"year":2018,"finding":"PMCA2 is required for estrogen receptor alpha (ERα) signaling in the female dorsal horn of the spinal cord. Female PMCA2+/- mice show increased mechanical pain sensitivity (52%) and reduced heat sensitivity (29%), while males do not. Intrathecal ERα agonist fails to activate ERα signaling in female PMCA2+/- mice but is effective in PMCA2+/+ females, establishing a female-specific link between PMCA2, ERα signaling, and pain modulation.","method":"Behavioral pain assays (von Frey, Hargreaves), ovariectomy/hormone replacement, intrathecal drug administration, western blotting of dorsal horn signaling proteins in PMCA2+/- vs +/+ mice","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2-3 — clean haploinsufficiency model with behavioral and molecular readouts, single lab","pmids":["30467368"],"is_preprint":false},{"year":2018,"finding":"PMCA2w/a splice variant in hair cell stereocilia increases its activity only marginally in response to rapid cytoplasmic Ca2+ elevation (unlike other PMCA2 variants which are strongly stimulated), enabling sustained calcium extrusion independent of calmodulin activation. Missense mutations of PMCA2w/a that cause deafness correlate with defects in homeostatic regulation of stereociliary Ca2+, decreased mechanotransduction channel sensitivity, and progressive organ of Corti degeneration.","method":"Biophysical and biochemical characterization of PMCA2w/a splice variant, mouse genetic models with functional hearing and calcium assays","journal":"Neuroscience letters","confidence":"High","confidence_rationale":"Tier 1 — biochemical characterization of splice-variant-specific functional property with multiple supporting mouse models","pmids":["29452611"],"is_preprint":false},{"year":2019,"finding":"NHERF1 interacts with PMCA2 at the apical membrane of secretory luminal epithelial cells during lactation and is required for proper apical localization of PMCA2. NHERF1 knockout disrupts PMCA2 apical targeting, impairs apical-basal polarity, and leads to premature Stat3 activation and lysosome-mediated mammary epithelial cell death. PMCA2 also interacts with the closely related NHERF2 at the apical membrane.","method":"Co-immunoprecipitation, immunofluorescence localization, NHERF1 knockout mice, Western blotting for Stat3 activation, lactation and involution phenotype analysis","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 — co-IP, knockout model with localization and signaling phenotypes, multiple orthogonal methods","pmids":["31087002"],"is_preprint":false},{"year":2019,"finding":"Decreased PMCA2 expression in the dorsal horn is paralleled by increased neuropathic pain in EAE (MS model) and spinal cord injury mice. In pure spinal cord neuronal cultures, IL-1β directly downregulates PMCA2 levels, acting as an effector that reduces neuronal PMCA2 expression and thereby perturbs calcium signaling contributing to pain sensitization.","method":"EAE and SCI mouse models, behavioral pain testing, Western blotting of dorsal horn PMCA2, cytokine profiling, pure SC neuronal culture treatment with IL-1β, TNFα, IL-6","journal":"Journal of neuroinflammation","confidence":"Medium","confidence_rationale":"Tier 2-3 — in vivo and in vitro correlated data, direct neuronal treatment identifies specific effector","pmids":["31703709"],"is_preprint":false},{"year":2023,"finding":"De novo ATP2B2 missense variants affecting evolutionarily conserved sites, and frameshift variants in the penultimate exon, cause a neurodevelopmental syndrome with ataxia, dystonia, intellectual disability, autism, and seizures. Cell-based functional studies showed that all variants caused significant alterations in cytosolic calcium handling with both loss- and gain-of-function effects, establishing that precise PMCA2-mediated calcium regulation is essential for neurodevelopment and cerebellar function.","method":"Exome/genome sequencing, trio-based genomics, in silico analyses, cell-based cytosolic calcium handling assays","journal":"Genetics in medicine","confidence":"High","confidence_rationale":"Tier 2 — functional calcium assays in cells for each variant combined with human genetic evidence, multiple variants tested","pmids":["37675773"],"is_preprint":false},{"year":2025,"finding":"A splice variant-dependent localization of PMCA2 to the lysosome was discovered. Lysosomal PMCA2 forms an evolutionarily conserved complex with NPC1 (the lysosomal membrane protein defective in Niemann-Pick disease type C). This lysosomal PMCA2-NPC1 interaction is involved in maintaining lysosomal calcium levels, and its disruption contributes to the pathophysiology of both NPC disease and Parkinson's disease, revealing a previously unrecognized intracellular role for PMCA2 in lysosomal calcium and lipid regulation.","method":"Splice variant localization studies, co-immunoprecipitation/complex identification with NPC1, lysosomal calcium measurements, disease models (NPC, Parkinson's)","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — novel localization discovery with complex identification and functional consequence, preprint not yet peer-reviewed","pmids":["bio_10.1101_2025.10.01.679724"],"is_preprint":true},{"year":2025,"finding":"ATP2B2 exhibits marked expression deficits at the synaptic proteome level in dorsolateral prefrontal cortex of individuals with schizophrenia. Structural analysis using AlphaFold3 models identified an enrichment of neuropsychiatric disease-associated deleterious missense variants in close spatial proximity to both the Ca2+ permeation tunnel and the ATP:Mg2+ coordination site. Cellular and biochemical analyses of canonical Ca2+-binding site variants confirmed clear loss-of-function effects on Ca2+ extrusion, linking genetic variants to impaired Ca2+ homeostasis in excitatory neurons.","method":"Single-nucleus RNA-seq, synaptic proteomics, AlphaFold3 structural modeling, case-control missense variant analysis, cellular/biochemical Ca2+ extrusion assays","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1-2 — structural modeling plus biochemical functional validation, preprint not yet peer-reviewed","pmids":["bio_10.1101_2025.08.25.672202"],"is_preprint":true},{"year":2025,"finding":"Exosomal PIP (prolactin-induced protein) from atrial fibrillation patients suppresses ATP2B2 expression, thereby inhibiting the cGMP/PKG signaling pathway and promoting myocardial fibrosis. ATP2B2 overexpression reversed the pro-fibrotic effects of PIP on cardiac fibroblasts and endothelial cells, while AAV-shPIP reduced AF incidence in rats. Activation of cGMP/PKG is beneficial for alleviating fibrosis, but this is mitigated by ATP2B2 knockdown.","method":"Exosome characterization, shRNA knockdown and overexpression of PIP and ATP2B2, CF and HUVEC functional assays, AAV-mediated shPIP in rat AF model, cGMP/PKG pathway analysis","journal":"Antioxidants & redox signaling","confidence":"Medium","confidence_rationale":"Tier 2 — gain and loss of function with pathway analysis in cells and in vivo rat model, single lab","pmids":["40094760"],"is_preprint":false}],"current_model":"ATP2B2/PMCA2 is a P-type Ca2+-ATPase that extrudes Ca2+ from the cytosol at the plasma membrane (primarily as the w/a splice variant in hair cell stereocilia), maintaining Ca2+ homeostasis in inner ear hair cells, cerebellar Purkinje neurons, and mammary epithelial cells; its activity is regulated by alternative splicing (governing calmodulin sensitivity, PDZ interactions, and subcellular targeting to apical vs. basolateral membranes), cortical cytoskeletal dynamics, and interactions with scaffold proteins (NHERF1/2, PSD-95), and it participates in multi-protein signaling complexes with mGluR1/Homer/IP3R1, HER2/HSP90, calcineurin/NFAT, and α7-nAChR/PSD-95 to regulate local calcium signaling and downstream apoptotic, proliferative, and synaptic processes; a lysosome-targeted splice variant additionally forms a complex with NPC1 to regulate lysosomal Ca2+ and lipid homeostasis relevant to neurodegeneration."},"narrative":{"teleology":[{"year":1992,"claim":"Molecular identity of PMCA2 was established by cloning the human ATP2B2 cDNA, revealing it as a distinct plasma membrane Ca²⁺-ATPase isoform with high interspecies conservation and mapping it to chromosome 3.","evidence":"cDNA cloning, sequencing, and somatic cell hybrid Southern blot analysis","pmids":["1427863"],"confidence":"High","gaps":["No functional characterization of pump activity at this stage","Tissue-specific expression pattern not yet determined"]},{"year":1993,"claim":"Alternative splicing at two regulatory sites (A and C) was shown to generate multiple PMCA2 isoforms with tissue-restricted expression (brain, skeletal muscle), establishing that splice variation is a major determinant of PMCA2 functional diversity.","evidence":"Quantitative RT-PCR with isoform-specific primers across seven human tissues","pmids":["8245032"],"confidence":"High","gaps":["Functional consequences of individual splice variants not yet measured","Subcellular targeting determinants of splice variants unknown"]},{"year":2001,"claim":"PMCA2b was found to interact selectively with PDZ-domain scaffold proteins (PSD-95, PSD-93, SAP97 but not SAP102) and colocalize with PSD-95 in hippocampal dendritic spines, establishing PMCA2 as a component of organized postsynaptic signaling complexes rather than an isolated pump.","evidence":"Yeast two-hybrid, co-immunoprecipitation, confocal immunofluorescence in MDCK cells and hippocampal neurons","pmids":["11274188"],"confidence":"High","gaps":["Functional consequence of PMCA2–scaffold interaction on local calcium dynamics not yet measured","Selectivity mechanism for SAP family members unclear"]},{"year":2004,"claim":"PMCA2 was localized to hair cell stereocilia and shown to be essential for endolymph calcium homeostasis: deafwaddler2J mice lacking stereociliary PMCA2 had significantly reduced endolymph Ca²⁺, directly linking pump activity to hearing and balance.","evidence":"Immunocytochemistry and Ca²⁺-sensitive fluorescent dye measurement in dfw2J versus control mouse endolymph","pmids":["15357414"],"confidence":"High","gaps":["Contribution of PMCA2 relative to other Ca²⁺ transport mechanisms in endolymph not quantified","Mechanism of progressive hair cell degeneration not delineated"]},{"year":2005,"claim":"The first human genetic evidence showed that a hypofunctional PMCA2 variant (V586M) acts as a modifier of sensorineural hearing loss severity across multiple families and etiologies, establishing PMCA2 as a clinically relevant modifier locus.","evidence":"Genetic analysis of human families with SNHL, functional characterization of V586M","pmids":["15829536"],"confidence":"High","gaps":["Precise biochemical defect of V586M debated—later studies showed it may not impair Ca²⁺ ejection directly","Population frequency and penetrance not fully defined"]},{"year":2006,"claim":"Splice-dependent membrane targeting was mechanistically resolved: the w-insert in the first intracellular loop drives apical targeting, while a Leu-Ile motif in the b-tail promotes basolateral sorting, explaining how the same gene achieves polarized distribution in different cell types.","evidence":"PMCA chimera mutagenesis and immunofluorescence targeting assays in hair cells and cell lines","pmids":["16803870"],"confidence":"High","gaps":["Binding partners that read the w-insert apical signal not identified","Whether targeting mechanism is identical in hair cells versus epithelial cells not resolved"]},{"year":2006,"claim":"PMCA2 was identified as a constituent of the mGluR1/Homer/IP3R1 signaling complex in cerebellum: PMCA2-null mice showed reduced levels of multiple complex members specifically in Purkinje neurons, revealing that PMCA2 is structurally required for complex integrity.","evidence":"Co-immunoprecipitation and immunohistochemistry in PMCA2-null versus wild-type mouse cerebellum","pmids":["17150372"],"confidence":"High","gaps":["Direct binding interface between PMCA2 and mGluR1 not mapped","Whether complex disruption is cause or consequence of Purkinje neuron dysfunction not fully dissected"]},{"year":2008,"claim":"The Oblivion (S877F) mutation demonstrated that a transmembrane domain substitution can abolish non-stimulated Ca²⁺ export while preserving correct plasma membrane targeting, dissecting pump activity from trafficking for the first time.","evidence":"ENU mutagenesis, immunofluorescence, biochemical/biophysical Ca²⁺ export assays in CHO cells expressing mutant PMCA2","pmids":["18974863"],"confidence":"High","gaps":["Structural basis for selective loss of basal versus stimulated activity not resolved","Whether similar mechanism applies to human hearing loss mutations unknown"]},{"year":2010,"claim":"Haploinsufficiency studies in heterozygous PMCA2 knockout mice established that PMCA2 is the rate-limiting calcium clearance mechanism in Purkinje dendrites: half-normal levels nearly doubled Ca²⁺ transient recovery time and degraded cerebellar motor output, while complete knockout showed elevated basal Ca²⁺, hyperpolarized membranes, and aberrant firing.","evidence":"Calcium imaging and whole-cell patch clamp in brain slices from PMCA2+/− and PMCA2−/− mice, beam-walking behavioral tests","pmids":["20083513","21232211"],"confidence":"High","gaps":["Contribution of compensatory mechanisms (SERCA, NCX) in knockout not fully quantified","Long-term neurodegenerative consequences not tracked"]},{"year":2010,"claim":"PMCA2 was shown to regulate apoptotic threshold in mammary epithelial cells: its downregulation during involution raises intracellular Ca²⁺ and sensitizes cells to apoptosis, while overexpression in breast cancer cells confers apoptosis resistance, revealing an oncologically relevant survival function.","evidence":"PMCA2 knockdown and overexpression in MECs and T47D breast cancer cells, calcium imaging, apoptosis assays, mammary gland involution model","pmids":["20534448"],"confidence":"High","gaps":["Transcriptional regulation of PMCA2 during involution not identified","Interaction with specific apoptotic effectors not mapped"]},{"year":2012,"claim":"Two parallel studies revealed that PMCA2 couples its Ca²⁺ extrusion activity to signaling complex regulation: it directly inhibits calcineurin/NFAT to suppress Fas Ligand-mediated apoptosis in breast cancer cells, and it constrains α7-nAChR-evoked calcium transients via PSD-95 scaffolding in hippocampal interneurons, with PMCA2 inhibition triggering CaMKII/proteasome-dependent receptor cluster loss.","evidence":"Co-immunoprecipitation, NFAT pathway and apoptosis assays in breast cancer cells; functional proteomics, calcium imaging, and single-particle tracking in hippocampal interneurons","pmids":["22962307","22593058"],"confidence":"High","gaps":["Calcineurin binding site on PMCA2 not mapped","Whether α7-nAChR cluster regulation occurs in vivo not tested"]},{"year":2012,"claim":"Chimeric pump experiments proved that the w-insert carries autonomous apical targeting information transferable to the normally basolateral PMCA4, and that NHERF2 PDZ-ligand optimization further enhances apical localization without altering intrinsic pump kinetics.","evidence":"Chimeric PMCA4(2w)/b constructs with mutagenesis in polarized epithelial cells, immunofluorescence, Ca²⁺ signaling assays","pmids":["22252018"],"confidence":"High","gaps":["Whether the w-insert interacts with specific coat or motor proteins for apical sorting unknown","In vivo validation in hair cells not performed with chimeric constructs"]},{"year":2016,"claim":"PMCA2 was found to interact with HER2 in actin-rich membrane domains and be required for HER2 membrane retention, HSP90 association, and downstream oncogenic signaling; PMCA2 knockout inhibited mammary tumor formation in MMTV-Neu mice, establishing PMCA2 as a functional partner in HER2-driven oncogenesis.","evidence":"Co-immunoprecipitation, PMCA2 knockdown/knockout, HER2 signaling and membrane localization assays, MMTV-Neu in vivo tumor model","pmids":["26729871"],"confidence":"High","gaps":["Direct versus calcium-mediated mechanism of HER2 stabilization not fully resolved","Therapeutic targetability of PMCA2–HER2 axis not explored"]},{"year":2017,"claim":"Cortical actin dynamics were identified as a direct modulator of PMCA2 specific activity: actin disruption enhanced and actin stabilization abolished Ca²⁺ extrusion without altering surface expression, indicating cytoskeletal gating of pump function.","evidence":"Real-time Ca²⁺ monitoring in PMCA2-transfected HEK293 cells treated with cytochalasin D and jasplakinolide, surface biotinylation","pmids":["28527708"],"confidence":"Medium","gaps":["Whether actin contacts the pump directly or via intermediary proteins unknown","Relevance to native stereociliary or dendritic actin dynamics not tested"]},{"year":2018,"claim":"Biophysical characterization showed that the PMCA2w/a splice variant uniquely provides sustained, calmodulin-independent Ca²⁺ extrusion with minimal activity modulation by rapid Ca²⁺ rises—a property essential for stereociliary calcium homeostasis—and that deafness-causing mutations specifically disrupt this homeostatic mode.","evidence":"Biochemical and biophysical characterization of PMCA2w/a, mouse genetic models with functional hearing and calcium assays","pmids":["29452611"],"confidence":"High","gaps":["Structural basis for calmodulin-independent activity of w/a variant not resolved","Whether other tissues exploit this constitutive extrusion mode unknown"]},{"year":2019,"claim":"NHERF1 was shown to be required for apical PMCA2 localization in lactating mammary epithelium; its loss mislocalized PMCA2, disrupted polarity, and triggered premature Stat3 activation and lysosome-mediated cell death, linking PMCA2 apical scaffolding to epithelial survival.","evidence":"Co-immunoprecipitation, NHERF1 knockout mice, immunofluorescence, Stat3 activation and lactation phenotype analysis","pmids":["31087002"],"confidence":"High","gaps":["Whether NHERF2 can compensate for NHERF1 loss not tested","Mechanism linking PMCA2 mislocalization to Stat3 activation not delineated"]},{"year":2023,"claim":"De novo ATP2B2 missense and frameshift variants were shown to cause a novel neurodevelopmental syndrome (ataxia, dystonia, intellectual disability, seizures) with both loss- and gain-of-function calcium handling defects, establishing that bidirectional disruption of PMCA2-mediated calcium homeostasis impairs neurodevelopment.","evidence":"Exome/genome sequencing in multiple families, trio-based analysis, cell-based cytosolic calcium handling assays for each variant","pmids":["37675773"],"confidence":"High","gaps":["Neurodevelopmental cellular mechanisms not elucidated","Genotype-phenotype correlation for gain- versus loss-of-function variants not fully established","No animal model recapitulating the full syndrome"]},{"year":null,"claim":"Key unresolved questions include the structural basis for calmodulin-independent activity of the w/a splice variant, the identity of apical sorting machinery that reads the w-insert signal, the direct versus calcium-mediated mechanism of HER2 stabilization, and the in vivo significance of lysosomal PMCA2–NPC1 complexes for neurodegeneration.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of full-length PMCA2 in any splice form","Mechanism by which w-insert directs apical sorting unknown","Lysosomal PMCA2–NPC1 complex reported only in preprint"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0,4,10,11,15,26]},{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[5,10,11,12,15,26]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,5,7,10,18,22,27]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[22,23]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,4,5,10,11,12,15,26]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8,16,17,22]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[13,16]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[3,8,12,14,17]},{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[5,6,26]}],"complexes":["mGluR1/Homer/IP3R1/PMCA2 complex","α7-nAChR/PSD-95/PMCA2 complex","PMCA2/HER2/HSP90 complex"],"partners":["DLG4","SLC9A3R1","SLC9A3R2","GRM1","HOMER3","ITPR1","ERBB2","PPP3CA"],"other_free_text":[]},"mechanistic_narrative":"ATP2B2 encodes PMCA2, a P-type Ca²⁺-ATPase that actively extrudes cytosolic calcium across the plasma membrane, functioning as the dominant calcium clearance mechanism in inner ear hair cell stereocilia and cerebellar Purkinje neuron dendrites [PMID:5357414, PMID:20083513]. Alternative splicing at the first intracellular loop (site A) and C-terminal tail (site C) generates isoforms with distinct calmodulin sensitivity, apical versus basolateral membrane targeting, and PDZ-domain scaffold interactions (NHERF1/2, PSD-95), with the w/a splice variant providing calmodulin-independent sustained Ca²⁺ extrusion in stereocilia [PMID:8245032, PMID:22252018, PMID:29452611, PMID:31087002]. PMCA2 participates in multi-protein signaling complexes—including mGluR1/Homer/IP3R1 in cerebellum, α7-nAChR/PSD-95 in hippocampus, and HER2/HSP90 in breast cancer cells—through which it couples local calcium homeostasis to synaptic function, receptor stability, calcineurin/NFAT-mediated apoptosis, and mammary gland involution [PMID:17150372, PMID:22593058, PMID:26729871, PMID:22962307, PMID:20534448]. De novo ATP2B2 missense and frameshift variants cause a neurodevelopmental syndrome featuring ataxia, dystonia, intellectual disability, and seizures, while hypofunctional variants modify sensorineural hearing loss severity [PMID:37675773, PMID:15829536]."},"prefetch_data":{"uniprot":{"accession":"Q01814","full_name":"Plasma membrane calcium-transporting ATPase 2","aliases":["Plasma membrane calcium ATPase isoform 2","Plasma membrane calcium pump isoform 2"],"length_aa":1243,"mass_kda":136.9,"function":"ATP-driven Ca(2+) ion pump involved in the maintenance of basal intracellular Ca(2+) levels in specialized cells of cerebellar circuit and vestibular and cochlear systems (PubMed:15829536, PubMed:17234811). Uses ATP as an energy source to transport cytosolic Ca(2+) ions across the plasma membrane to the extracellular compartment (PubMed:15829536, PubMed:17234811). Has fast activation and Ca(2+) clearance rate suited to control fast neuronal Ca(2+) dynamics. At parallel fiber to Purkinje neuron synapse, mediates presynaptic Ca(2+) efflux in response to climbing fiber-induced Ca(2+) rise. Provides for fast return of Ca(2+) concentrations back to their resting levels, ultimately contributing to long-term depression induction and motor learning (By similarity). Plays an essential role in hearing and balance (PubMed:15829536, PubMed:17234811). In cochlear hair cells, shuttles Ca(2+) ions from stereocilia to the endolymph and dissipates Ca(2+) transients generated by the opening of the mechanoelectrical transduction channels. Regulates Ca(2+) levels in the vestibular system, where it contributes to the formation of otoconia (PubMed:15829536, PubMed:17234811). In non-excitable cells, regulates Ca(2+) signaling through spatial control of Ca(2+) ions extrusion and dissipation of Ca(2+) transients generated by store-operated channels (PubMed:25690014). In lactating mammary gland, allows for the high content of Ca(2+) ions in the milk (By similarity)","subcellular_location":"Basolateral cell membrane","url":"https://www.uniprot.org/uniprotkb/Q01814/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ATP2B2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ATP2B2","total_profiled":1310},"omim":[{"mim_id":"619804","title":"DEAFNESS, AUTOSOMAL DOMINANT 82; DFNA82","url":"https://www.omim.org/entry/619804"},{"mim_id":"613792","title":"CHROMOSOME 3pter-p25 DELETION SYNDROME","url":"https://www.omim.org/entry/613792"},{"mim_id":"607806","title":"OTOPETRIN 1; OTOP1","url":"https://www.omim.org/entry/607806"},{"mim_id":"605516","title":"CADHERIN 23; CDH23","url":"https://www.omim.org/entry/605516"},{"mim_id":"603963","title":"INTEGRIN, ALPHA-9; ITGA9","url":"https://www.omim.org/entry/603963"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":88.0},{"tissue":"choroid plexus","ntpm":61.0},{"tissue":"salivary gland","ntpm":31.3},{"tissue":"skeletal muscle","ntpm":35.1}],"url":"https://www.proteinatlas.org/search/ATP2B2"},"hgnc":{"alias_symbol":["PMCA2"],"prev_symbol":[]},"alphafold":{"accession":"Q01814","domains":[{"cath_id":"2.70.150.10","chopping":"31-86_209-289","consensus_level":"high","plddt":84.4845,"start":31,"end":289},{"cath_id":"1.20.1110.10","chopping":"386-473_867-928_950-1097","consensus_level":"medium","plddt":83.8227,"start":386,"end":1097},{"cath_id":"3.40.50.1000","chopping":"480-505_712-857","consensus_level":"medium","plddt":86.4566,"start":480,"end":857},{"cath_id":"3.40.1110.10","chopping":"511-707","consensus_level":"high","plddt":86.9423,"start":511,"end":707},{"cath_id":"1.10.287","chopping":"98-128_149-188","consensus_level":"high","plddt":74.0665,"start":98,"end":188}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q01814","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q01814-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q01814-F1-predicted_aligned_error_v6.png","plddt_mean":73.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ATP2B2","jax_strain_url":"https://www.jax.org/strain/search?query=ATP2B2"},"sequence":{"accession":"Q01814","fasta_url":"https://rest.uniprot.org/uniprotkb/Q01814.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q01814/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q01814"}},"corpus_meta":[{"pmid":"15829536","id":"PMC_15829536","title":"Modification of human hearing loss by plasma-membrane calcium pump PMCA2.","date":"2005","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15829536","citation_count":141,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20534448","id":"PMC_20534448","title":"PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancer.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20534448","citation_count":99,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15357414","id":"PMC_15357414","title":"Low endolymph calcium concentrations in deafwaddler2J mice suggest that PMCA2 contributes to endolymph calcium maintenance.","date":"2004","source":"Journal of the Association for Research in Otolaryngology : JARO","url":"https://pubmed.ncbi.nlm.nih.gov/15357414","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26729871","id":"PMC_26729871","title":"PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26729871","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18974863","id":"PMC_18974863","title":"The novel mouse mutation Oblivion inactivates the PMCA2 pump and causes progressive hearing loss.","date":"2008","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18974863","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20826782","id":"PMC_20826782","title":"The novel PMCA2 pump mutation Tommy impairs cytosolic calcium clearance in hair cells and links to deafness in mice.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20826782","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16803870","id":"PMC_16803870","title":"Molecular determinants for differential membrane trafficking of PMCA1 and PMCA2 in mammalian hair cells.","date":"2006","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/16803870","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27148852","id":"PMC_27148852","title":"The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27148852","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17150372","id":"PMC_17150372","title":"Molecular alterations in the cerebellum of the plasma membrane calcium ATPase 2 (PMCA2)-null mouse indicate abnormalities in Purkinje neurons.","date":"2006","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/17150372","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21757185","id":"PMC_21757185","title":"Converging evidence for an association of ATP2B2 allelic variants with autism in male subjects.","date":"2011","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/21757185","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20083513","id":"PMC_20083513","title":"Reduced expression of the Ca(2+) transporter protein PMCA2 slows Ca(2+) dynamics in mouse cerebellar Purkinje neurones and alters the precision of motor coordination.","date":"2010","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20083513","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22962307","id":"PMC_22962307","title":"Disruption of the interaction between PMCA2 and calcineurin triggers apoptosis and enhances paclitaxel-induced cytotoxicity in breast cancer cells.","date":"2012","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/22962307","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30535804","id":"PMC_30535804","title":"De novo and inherited loss-of-function variants of ATP2B2 are associated with rapidly progressive hearing impairment.","date":"2018","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30535804","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8187550","id":"PMC_8187550","title":"Localization of two genes encoding plasma membrane Ca2+ ATPases isoforms 2 (ATP2B2) and 3 (ATP2B3) to human chromosomes 3p26-->p25 and Xq28, respectively.","date":"1994","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8187550","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1427863","id":"PMC_1427863","title":"Determination of the nucleotide sequence and chromosomal localization of the ATP2B2 gene encoding human Ca(2+)-pumping ATPase isoform PMCA2.","date":"1992","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1427863","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16675132","id":"PMC_16675132","title":"Atp2b2, encoding plasma membrane Ca2+-ATPase type 2, (PMCA2) exhibits tissue-specific first exon usage in hair cells, neurons, and mammary glands of mice.","date":"2006","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16675132","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22593058","id":"PMC_22593058","title":"PMCA2 via PSD-95 controls calcium signaling by α7-containing nicotinic acetylcholine receptors on aspiny interneurons.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22593058","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23620727","id":"PMC_23620727","title":"The evidence for association of ATP2B2 polymorphisms with autism in Chinese Han population.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23620727","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29085954","id":"PMC_29085954","title":"Characterizations of PMCA2-interacting complex and its role as a calcium oxalate crystal-binding protein.","date":"2017","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/29085954","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22047666","id":"PMC_22047666","title":"Mutations in PMCA2 and hereditary deafness: a molecular analysis of the pump defect.","date":"2011","source":"Cell calcium","url":"https://pubmed.ncbi.nlm.nih.gov/22047666","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22921123","id":"PMC_22921123","title":"Downregulation of PMCA2 or PMCA3 reorganizes Ca(2+) handling systems in differentiating PC12 cells.","date":"2012","source":"Cell calcium","url":"https://pubmed.ncbi.nlm.nih.gov/22921123","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16845470","id":"PMC_16845470","title":"A de novo deafwaddler mutation of Pmca2 arising in ES cells and hitchhiking with a targeted modification of the Pparg gene.","date":"2006","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/16845470","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21232211","id":"PMC_21232211","title":"The role of the calcium transporter protein plasma membrane calcium ATPase PMCA2 in cerebellar Purkinje neuron function.","date":"2010","source":"Functional neurology","url":"https://pubmed.ncbi.nlm.nih.gov/21232211","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27613092","id":"PMC_27613092","title":"PMCA2 silencing potentiates MDA-MB-231 breast cancer cell death initiated with the Bcl-2 inhibitor ABT-263.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/27613092","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23792079","id":"PMC_23792079","title":"A new Atp2b2 deafwaddler allele, dfw(i5), interacts strongly with Cdh23 and other auditory modifiers.","date":"2013","source":"Hearing research","url":"https://pubmed.ncbi.nlm.nih.gov/23792079","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37675773","id":"PMC_37675773","title":"ATP2B2 de novo variants as a cause of variable neurodevelopmental disorders that feature dystonia, ataxia, intellectual disability, behavioral symptoms, and seizures.","date":"2023","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37675773","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11124466","id":"PMC_11124466","title":"Effects of PMCA2 mutation on DPOAE amplitudes and latencies in deafwaddler mice.","date":"2001","source":"Hearing research","url":"https://pubmed.ncbi.nlm.nih.gov/11124466","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11875276","id":"PMC_11875276","title":"PMCA2 mutation causes structural changes in the auditory system in deafwaddler mice.","date":"2001","source":"Journal of neurocytology","url":"https://pubmed.ncbi.nlm.nih.gov/11875276","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30467368","id":"PMC_30467368","title":"A link between plasma membrane calcium ATPase 2 (PMCA2), estrogen and estrogen receptor α signaling in mechanical pain.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30467368","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24269647","id":"PMC_24269647","title":"Downregulation of PMCA2 increases the vulnerability of midbrain neurons to mitochondrial complex I inhibition.","date":"2013","source":"Neurotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/24269647","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18848933","id":"PMC_18848933","title":"Reductions in motor unit number estimates (MUNE) precede motor neuron loss in the plasma membrane calcium ATPase 2 (PMCA2)-heterozygous mice.","date":"2008","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18848933","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27076938","id":"PMC_27076938","title":"PON2 and ATP2B2 gene polymorphisms with noise-induced hearing loss.","date":"2016","source":"Journal of thoracic disease","url":"https://pubmed.ncbi.nlm.nih.gov/27076938","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29452611","id":"PMC_29452611","title":"PMCA2 pump mutations and hereditary deafness.","date":"2018","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/29452611","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27702770","id":"PMC_27702770","title":"Impaired sensitivity to pain stimuli in plasma membrane calcium ATPase 2 (PMCA2) heterozygous mice: a possible modality- and sex-specific role for PMCA2 in nociception.","date":"2016","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/27702770","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31087002","id":"PMC_31087002","title":"NHERF1 Is Required for Localization of PMCA2 and Suppression of Early Involution in the Female Lactating Mammary Gland.","date":"2019","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31087002","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31703709","id":"PMC_31703709","title":"Pathological pain processing in mouse models of multiple sclerosis and spinal cord injury: contribution of plasma membrane calcium ATPase 2 (PMCA2).","date":"2019","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/31703709","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23826306","id":"PMC_23826306","title":"Two ENU-induced alleles of Atp2b2 cause deafness in mice.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23826306","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24288624","id":"PMC_24288624","title":"The plasma membrane Ca2+-ATPase2 (PMCA2) is involved in the regulation of Purkinje cell dendritic growth in cerebellar organotypic slice cultures.","date":"2013","source":"Neural plasticity","url":"https://pubmed.ncbi.nlm.nih.gov/24288624","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21325754","id":"PMC_21325754","title":"Identification of a novel point mutation of mouse Atp2b2 induced by N-ethyl-N-nitrosourea mutagenesis.","date":"2011","source":"Experimental animals","url":"https://pubmed.ncbi.nlm.nih.gov/21325754","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28527708","id":"PMC_28527708","title":"Cortical cytoskeleton dynamics regulates plasma membrane calcium ATPase isoform-2 (PMCA2) activity.","date":"2017","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/28527708","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22252018","id":"PMC_22252018","title":"Plasma membrane calcium pump (PMCA) isoform 4 is targeted to the apical membrane by the w-splice insert from PMCA2.","date":"2012","source":"Cell calcium","url":"https://pubmed.ncbi.nlm.nih.gov/22252018","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24799196","id":"PMC_24799196","title":"Changes in cochlear PMCA2 expression correlate with the maturation of auditory sensitivity.","date":"2014","source":"Journal of the Association for Research in Otolaryngology : JARO","url":"https://pubmed.ncbi.nlm.nih.gov/24799196","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9284946","id":"PMC_9284946","title":"The human chromosome 3 gene cluster ACY1-CACNA1D-ZNF64-ATP2B2 is evolutionarily conserved in Ateles paniscus chamek (Platyrrhini, Primates).","date":"1997","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9284946","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31886164","id":"PMC_31886164","title":"Research and Discussion on the Relationships between Noise-Induced Hearing Loss and ATP2B2 Gene Polymorphism.","date":"2019","source":"International journal of genomics","url":"https://pubmed.ncbi.nlm.nih.gov/31886164","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7587388","id":"PMC_7587388","title":"Colocalization of the rat homolog of the von Hippel Lindau (Vhl) gene and the plasma membrane Ca++ transporting ATPase isoform 2 (Atp2b2) gene to rat chromosome bands 4q41.3-->42.1.","date":"1995","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7587388","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30546427","id":"PMC_30546427","title":"Differential expression of PMCA2 mRNA isoforms in a cohort of Spanish patients with breast tumor types.","date":"2018","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/30546427","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21798237","id":"PMC_21798237","title":"GABA-shunt enzymes activity in GH3 cells with reduced level of PMCA2 or PMCA3 isoform.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21798237","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17336006","id":"PMC_17336006","title":"Plasma membrane Ca2+-ATPase isoforms in frog crista ampullaris: identification of PMCA1 and PMCA2 specific splice variants.","date":"2007","source":"Hearing research","url":"https://pubmed.ncbi.nlm.nih.gov/17336006","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29452612","id":"PMC_29452612","title":"Survival strategies for mouse cerebellar Purkinje neurons lacking PMCA2.","date":"2018","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/29452612","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40094760","id":"PMC_40094760","title":"Exosomal Prolactin-Induced Protein Inhibits the Activation of cGMP/PKG Pathway Mediated by ATP2B2 to Promote Myocardial Fibrosis in Atrial Fibrillation.","date":"2025","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/40094760","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38907191","id":"PMC_38907191","title":"Preliminary research on LncRNA ATP2B2-IT2 in neovascularization of diabetic retinopathy.","date":"2024","source":"BMC ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/38907191","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38628728","id":"PMC_38628728","title":"Genetic variants in ATP2B2 as risk factors for mortality in patients unrelated but not associated with families with severe COVID-19.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/38628728","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40446761","id":"PMC_40446761","title":"Immunolabel imaging of plasma membrane Ca++ pumps (PMCA-pan or PMCA2) implicates the apical cilium on receptor cells as the transduction site for electrosense in two Acipenseriformes fishes.","date":"2025","source":"Tissue & cell","url":"https://pubmed.ncbi.nlm.nih.gov/40446761","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39367743","id":"PMC_39367743","title":"Consolidating the Role of Mutated ATP2B2 in Neurodevelopmental and Cerebellar Pathologies.","date":"2024","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39367743","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39834499","id":"PMC_39834499","title":"Immunotherapy Responsive Recurrent Post-Infectious Ataxia Associated With Recurrent ATP2B2 Gene Variant.","date":"2025","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39834499","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.10.01.679724","title":"Alternate Splicing Directs PMCA2 to Lysosomes and is Linked to Neurodegeneration","date":"2025-10-02","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.01.679724","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.02.10.637526","title":"Nanoprotrusion enlargement conducts cytocapsular tube elongation along the path of least resistance for metastasis initiation","date":"2025-02-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.10.637526","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.10.01.616146","title":"Erbin interacts with NHERF1 and Ezrin to stabilize a membrane ErbB2 signaling complex in HER2-positive breast cancer","date":"2024-10-03","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.01.616146","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.09.17.676758","title":"Proteomic and Kinetic Characterization of Prion Seeding in Distinct Human CJD Strains Unveils Early Diagnostic Biomarkers","date":"2025-09-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.17.676758","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.08.25.672202","title":"Genetics-to-structure multiscale analysis identifies disrupted calcium homeostasis as a mechanism of psychiatric disease","date":"2025-08-27","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.25.672202","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.05.05.652224","title":"Early downregulation of hair cell (HC)-specific genes in the vestibular sensory epithelium during chronic ototoxicity","date":"2025-05-09","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.05.652224","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"30280653","id":"PMC_30280653","title":"Blood-Brain Barrier: From Physiology to Disease and Back.","date":"2019","source":"Physiological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/30280653","citation_count":1645,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11076863","id":"PMC_11076863","title":"DNA cloning using in vitro site-specific recombination.","date":"2000","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11076863","citation_count":815,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8634322","id":"PMC_8634322","title":"Structural organization, ion transport, and energy transduction of P-type ATPases.","date":"1996","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/8634322","citation_count":618,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33060197","id":"PMC_33060197","title":"Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.","date":"2020","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/33060197","citation_count":564,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33845483","id":"PMC_33845483","title":"Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33845483","citation_count":532,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11152753","id":"PMC_11152753","title":"Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps.","date":"2001","source":"Physiological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/11152753","citation_count":469,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15071553","id":"PMC_15071553","title":"Biology, structure and mechanism of P-type ATPases.","date":"2004","source":"Nature reviews. Molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15071553","citation_count":447,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26638075","id":"PMC_26638075","title":"A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26638075","citation_count":433,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22810586","id":"PMC_22810586","title":"Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins.","date":"2012","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22810586","citation_count":319,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27342126","id":"PMC_27342126","title":"Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27342126","citation_count":306,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18591664","id":"PMC_18591664","title":"Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18591664","citation_count":241,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2963820","id":"PMC_2963820","title":"Identification and primary structure of a calmodulin binding domain of the Ca2+ pump of human erythrocytes.","date":"1988","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2963820","citation_count":227,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26618866","id":"PMC_26618866","title":"∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26618866","citation_count":209,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22895189","id":"PMC_22895189","title":"Genome-wide association study indicates two novel resistance loci for severe malaria.","date":"2012","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22895189","citation_count":193,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30442766","id":"PMC_30442766","title":"LZTR1 is a regulator of RAS ubiquitination and signaling.","date":"2018","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/30442766","citation_count":180,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23602568","id":"PMC_23602568","title":"The protein interaction landscape of the human CMGC kinase group.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/23602568","citation_count":174,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2137451","id":"PMC_2137451","title":"Peptide sequence analysis and molecular cloning reveal two calcium pump isoforms in the human erythrocyte membrane.","date":"1990","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2137451","citation_count":162,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25468996","id":"PMC_25468996","title":"E-cadherin interactome complexity and robustness resolved by quantitative proteomics.","date":"2014","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/25468996","citation_count":162,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11230166","id":"PMC_11230166","title":"Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.","date":"2001","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11230166","citation_count":151,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11274188","id":"PMC_11274188","title":"Plasma membrane Ca2+-atpase isoforms 2b and 4b interact promiscuously and selectively with members of the membrane-associated guanylate kinase family of PDZ (PSD95/Dlg/ZO-1) domain-containing proteins.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11274188","citation_count":143,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8245032","id":"PMC_8245032","title":"Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8245032","citation_count":141,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":31880,"output_tokens":5419,"usd":0.088462},"stage2":{"model":"claude-opus-4-6","input_tokens":9056,"output_tokens":3524,"usd":0.20007},"total_usd":0.68253,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":44765,"output_tokens":8579,"usd":0.13149},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":12601,"output_tokens":4480,"usd":0.262508}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"ATP2B2 encodes the plasma membrane Ca2+-pumping ATPase isoform PMCA2, responsible for maintaining calcium homeostasis in eukaryotic cells; the human and rat protein sequences share >98% homology and the gene is located on chromosome 3.\",\n      \"method\": \"cDNA cloning, sequencing, somatic cell hybrid Southern blotting\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original gene identification with sequence characterization\",\n      \"pmids\": [\"1427863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"ATP2B2 (encoding PMCA2) was localized to human chromosome 3p26→p25 by fluorescence in situ hybridization and somatic cell hybrid analysis.\",\n      \"method\": \"FISH, somatic cell hybrid analysis, genetic linkage\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct cytogenetic mapping with multiple orthogonal methods\",\n      \"pmids\": [\"8187550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PMCA2 is localized to hair cell stereocilia where it pumps calcium into the endolymph; loss of PMCA2 in deafwaddler2J mice significantly lowers endolymph calcium concentrations, demonstrating that PMCA2 is a primary contributor to endolymph calcium maintenance.\",\n      \"method\": \"Immunocytochemistry for PMCA2 localization; calcium-sensitive fluorescent dye measurement of endolymph calcium in dfw2J knockout mice\",\n      \"journal\": \"Journal of the Association for Research in Otolaryngology : JARO\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment combined with functional knockout phenotype and calcium measurement\",\n      \"pmids\": [\"15357414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"A heterozygous hypofunctional variant V586M in PMCA2 (ATP2B2) acts as a modifier of sensorineural hearing loss caused by mutations in CDH23 or MYO6, demonstrating that PMCA2 activity level modulates severity of hearing loss from diverse causes.\",\n      \"method\": \"Genetic evaluation of human families; functional characterization of V586M variant\",\n      \"journal\": \"The New England journal of medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human genetic epistasis with functional variant characterization, replicated across unrelated individuals\",\n      \"pmids\": [\"15829536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Apical targeting of PMCA2 to hair cell stereocilia depends on the size of the alternatively spliced A-site insert (w-insert), while a Leu-Ile motif in 'b'-tail splice variants promotes basolateral sorting; these molecular determinants explain differential subcellular localization of PMCA isoforms in hair cells.\",\n      \"method\": \"Transfection and immunofluorescence targeting studies in hair cells; splice variant expression analysis\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiments with defined molecular determinants, functional consequence for Ca2+ extrusion site\",\n      \"pmids\": [\"16803870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PMCA2 co-immunoprecipitates with mGluR1, Homer 3, and IP3R1 in cerebellar Purkinje neurons, indicating PMCA2 is a constituent of the mGluR1 signaling complex; loss of PMCA2 reduces levels of mGluR1, IP3R1, Homer 1b/c, and Homer 3 specifically in the cerebellum, disrupting metabotropic glutamate receptor signaling.\",\n      \"method\": \"Co-immunoprecipitation, Western blotting, immunofluorescence in PMCA2-null mice\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with multiple binding partners, KO mouse with specific molecular phenotype\",\n      \"pmids\": [\"17150372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Atp2b2 uses four distinct tissue-specific transcriptional start sites (alpha, beta, mu, delta) generating different 5'-UTR isoforms; the alpha transcript dominates in cochlear hair cells and cerebellar Purkinje neurons, while mu and delta are enriched in lactating mammary gland, demonstrating tissue-specific transcriptional regulation of PMCA2 expression.\",\n      \"method\": \"5'-RACE, real-time RT-PCR, in situ hybridization, cochlear microdissection\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods establishing tissue-specific transcript usage with functional implications\",\n      \"pmids\": [\"16675132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The Oblivion (Obl) ENU-induced missense mutation S877F in transmembrane domain 6 of PMCA2 correctly targets to the plasma membrane but significantly reduces non-stimulated Ca2+ exporting ability, causing progressive base-to-apex hair cell degeneration and progressive hearing loss.\",\n      \"method\": \"ENU mutagenesis, mutation mapping, immunofluorescence of hair cells, biochemical and biophysical Ca2+ pump characterization in model cells\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro pump activity assay combined with in vivo hair cell imaging and mutagenesis\",\n      \"pmids\": [\"18974863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PMCA2 down-regulation during mammary involution raises intracellular calcium and sensitizes mammary epithelial cells to apoptosis; conversely, PMCA2 overexpression in T47D breast cancer cells lowers intracellular calcium and protects against apoptosis, establishing PMCA2 as a regulator of calcium-mediated apoptosis.\",\n      \"method\": \"Expression knockdown/overexpression in mammary cells, intracellular calcium measurement, apoptosis assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — bidirectional manipulation (KD and OE) with calcium and apoptosis readouts, mechanistic link established\",\n      \"pmids\": [\"20534448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The Tommy ENU mutation E629K in the second intracellular loop (active site) of PMCA2 inhibits long-term non-stimulated calcium extrusion, impairing cytosolic calcium clearance in hair cells as shown by flash photolysis of caged calcium in utricle organotypic cultures.\",\n      \"method\": \"ENU mutagenesis, CHO cell Ca2+ extrusion assay, confocal imaging with flash photolysis of caged Ca2+ in organotypic cultures, immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct in vitro pump activity measurement, live cell calcium imaging in native hair cells, mutagenesis\",\n      \"pmids\": [\"20826782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Reduction of PMCA2 expression by 50% in heterozygous knockout Purkinje neurons nearly doubles calcium transient recovery times, prolongs Ca2+-dependent K+ currents, slows action potential firing frequency, and impairs hindlimb motor coordination on a narrow beam, establishing PMCA2 as the primary determinant of calcium clearance kinetics in Purkinje cell dendrites.\",\n      \"method\": \"PMCA2+/- mouse model, two-photon calcium imaging, whole-cell patch clamp, behavioral beam-walking assay\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic model with multiple orthogonal electrophysiology/imaging/behavioral readouts\",\n      \"pmids\": [\"20083513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Analysis of PMCA2w/a pump mutants (mouse V586M and human analogue) reveals that the w/a splice variant has constitutively high basal Ca2+ extrusion activity independent of calmodulin; mouse mutants show defects in both basal pump activity and long-range Ca2+ ejection, while the human variant fails to impair Ca2+ ejection, explaining the modifier vs. causative roles.\",\n      \"method\": \"Overexpression of mutant PMCA2w/a in model cells, calcium extrusion assays\",\n      \"journal\": \"Cell calcium\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro pump activity reconstitution with defined mutants, mechanistic differentiation of variant effects\",\n      \"pmids\": [\"22047666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PMCA2 is physically associated with α7-nicotinic acetylcholine receptors (α7-nAChRs) and the scaffold protein PSD-95 at aspiny dendrites of hippocampal interneurons; PMCA2 activity limits the duration of α7-nAChR-induced calcium elevations, and PMCA2 inhibition triggers rapid CaMKII- and proteasome-dependent loss of α7-nAChR clusters dependent on PSD-95 and the second intracellular loop of α7-nAChR.\",\n      \"method\": \"Functional proteomics (pulldown from rat brain), calcium imaging in hippocampal interneuron cultures, single-particle tracking, pharmacological inhibition\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mass spectrometry interactome plus functional calcium imaging, single-particle tracking, and pharmacological dissection of mechanism\",\n      \"pmids\": [\"22593058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PMCA2 physically interacts with calcineurin in breast cancer cells (inhibitory interaction); disruption of this interaction activates the calcineurin/NFAT pathway, upregulates pro-apoptotic Fas Ligand expression, and induces apoptosis, enhancing paclitaxel-mediated cytotoxicity.\",\n      \"method\": \"Co-immunoprecipitation, calcineurin/NFAT pathway assay, FasL expression measurement, cell viability and apoptosis assays\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP establishes interaction, functional disruption assay links PMCA2-calcineurin interaction to defined downstream signaling and apoptosis outcome\",\n      \"pmids\": [\"22962307\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The w-splice insert from PMCA2 confers autonomous apical membrane targeting when transferred to the normally basolateral PMCA4 isoform, and optimizing the PDZ ligand site for NHERF2 interaction further enhances apical localization; isoform-specific functional characteristics are retained regardless of membrane targeting.\",\n      \"method\": \"Chimeric PMCA4/PMCA2w construct expression in polarized cells, immunofluorescence, ATP-induced Ca2+ signal kinetics measurement\",\n      \"journal\": \"Cell calcium\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — domain swap experiment with functional readout demonstrating autonomous targeting signal\",\n      \"pmids\": [\"22252018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PMCA2 interacts with HER2 in actin-rich membrane domains; knocking down PMCA2 raises intracellular calcium, disrupts HER2–HSP90 interactions, inhibits HER2 signaling, and causes HER2 internalization and degradation; knockout of PMCA2 inhibits mammary tumor formation in MMTV-Neu mice.\",\n      \"method\": \"Co-immunoprecipitation, PMCA2 knockdown/knockout, HER2 signaling assays, intracellular calcium measurement, MMTV-Neu tumor formation assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (Co-IP, KD, KO mouse model) with defined molecular and cellular phenotypes\",\n      \"pmids\": [\"26729871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Disruption of the actin cytoskeleton (cytochalasin D) significantly increases PMCA2-mediated Ca2+ extrusion (~50–100%) whereas F-actin stabilization (jasplakinolide) fully inhibits it; microtubule disruption (colchicine) decreases PMCA activity by ~40–60%, without altering surface expression, demonstrating that the cortical cytoskeleton dynamically regulates PMCA2 specific activity.\",\n      \"method\": \"Live cell cytosolic calcium monitoring in HEK293 cells expressing PMCA2, pharmacological cytoskeleton manipulation, cell surface expression quantification\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — live cell functional assay with pharmacological tools, single lab\",\n      \"pmids\": [\"28527708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PMCA2-interacting complex in kidney cells (identified by IP-MS) includes 474 proteins; functional validation reveals PMCA2 acts as a calcium oxalate monohydrate (COM) crystal-binding protein on the cell surface, mediating crystal retention and internalization relevant to kidney stone pathogenesis.\",\n      \"method\": \"Immunoprecipitation followed by nanoLC-ESI-Qq-TripleTOF MS/MS, quantitative immuno-co-localization, COM crystal-protein binding/adhesion/internalization assays, antibody neutralization\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — MS interactome plus functional crystal-binding assay, single lab study\",\n      \"pmids\": [\"29085954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NHERF1 interacts with PMCA2 at the apical membrane of lactating mammary epithelial cells and is required for proper apical localization of PMCA2; loss of NHERF1 disrupts PMCA2 apical targeting, perturbs apical-basal polarity, and leads to premature Stat3 activation and lysosome-mediated mammary gland involution. PMCA2 also interacts with NHERF2 at the apical membrane.\",\n      \"method\": \"Co-immunoprecipitation, NHERF1 knockout mouse model, immunofluorescence, Western blotting for Stat3 activation\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus KO mouse with defined molecular and cellular phenotypes; orthogonal localization and signaling readouts\",\n      \"pmids\": [\"31087002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PMCA2 is essential for estrogen receptor alpha (ERα) signaling in female dorsal horn neurons; PMCA2+/- female mice show increased mechanical pain sensitivity and failed analgesic response to 17β-estradiol, with impaired ERα signaling after intrathecal ERα agonist administration, establishing a female-specific PMCA2–ERα–pain axis.\",\n      \"method\": \"PMCA2+/- mouse behavioral pain assays (mechanical/thermal), ovariectomy/E2 replacement, intrathecal ERα agonist, Western blotting of ERα signaling in dorsal horn\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic model with pharmacological and biochemical validation; single lab\",\n      \"pmids\": [\"30467368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PMCA2 expression in dorsal horn neurons is decreased in experimental autoimmune encephalomyelitis (EAE) and spinal cord injury models that produce neuropathic pain; IL-1β directly downregulates PMCA2 levels in pure spinal cord neuronal cultures by acting on neurons, identifying IL-1β as a molecular effector reducing PMCA2 and thereby contributing to neuropathic pain.\",\n      \"method\": \"PMCA2 Western blotting in EAE and SCI mice DH; IL-1β, TNFα, IL-6 measurement; pure neuronal culture treatment with cytokines\",\n      \"journal\": \"Journal of neuroinflammation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — in vivo correlation plus direct neuronal culture experiment linking IL-1β to PMCA2 downregulation; single lab\",\n      \"pmids\": [\"31703709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"De novo missense ATP2B2 variants affecting conserved sites and frameshift variants cause a spectrum of neurodevelopmental disorders (ataxia, dystonia, intellectual disability, autism, seizures); cell-based studies show all tested variants cause significant alterations in cytosolic calcium handling with both loss- and gain-of-function effects on PMCA2 activity.\",\n      \"method\": \"Exome/genome sequencing (trio-based), in silico analysis, cell-based cytosolic calcium handling assays for each variant\",\n      \"journal\": \"Genetics in medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional cell-based calcium assays for multiple variants combined with human genetics; multinational cohort\",\n      \"pmids\": [\"37675773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A splice variant-dependent localization of PMCA2 to the lysosome was identified; at the lysosome, PMCA2 forms an evolutionarily conserved complex with NPC1 (the Niemann-Pick type C lysosomal membrane protein), maintaining lysosomal calcium levels; disruption of this interaction contributes to pathophysiology of NPC disease and Parkinson's disease.\",\n      \"method\": \"Splice variant expression, subcellular fractionation/imaging of lysosomal localization, co-immunoprecipitation with NPC1, lysosomal calcium measurement, disease model validation\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP with NPC1, localization imaging, calcium measurements in disease models; preprint, not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.10.01.679724\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"PMCA2 (ATP2B2) is a plasma membrane calcium ATPase that primarily functions as the principal Ca2+ efflux pump in hair cell stereocilia (using its constitutively active w/a splice variant to export Ca2+ into endolymph independent of calmodulin), in cerebellar Purkinje neurons (where it sets the kinetics of cytosolic Ca2+ clearance and thereby controls firing patterns and motor coordination), and in lactating mammary epithelial cells (where it transports Ca2+ into milk and prevents apoptosis by lowering intracellular Ca2+); additionally, PMCA2 organizes multi-protein signaling complexes by interacting with HER2/ErbB2, HSP90, NHERF1/2, calcineurin, mGluR1/Homer/IP3R1, PSD-95, and α7-nAChRs, and a lysosomal splice variant forms a complex with NPC1 to regulate lysosomal calcium homeostasis relevant to neurodegeneration.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"The human ATP2B2 gene was isolated and characterized, encoding a plasma membrane Ca2+-pumping ATPase isoform PMCA2. Human and rat cDNA sequences showed 95% homology in the coding domain and >98% homology at the deduced protein sequence level. The gene was localized to human chromosome 3.\",\n      \"method\": \"cDNA cloning, sequencing, somatic cell hybrid Southern blot analysis\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original molecular characterization with cDNA cloning and sequencing\",\n      \"pmids\": [\"1427863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"PMCA2 undergoes alternative splicing at two major regulatory sites (site A in the first intracellular loop and site C in the C-terminal calmodulin-binding domain), generating multiple isoforms. PMCA2 and PMCA3 transcripts are expressed in a tissue-specific manner, with highest levels in fetal skeletal muscle and brain, in contrast to the ubiquitous PMCA1 and PMCA4.\",\n      \"method\": \"Quantitative RT-PCR with isoform-specific primers across seven human tissues\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative molecular analysis across multiple tissues with isoform-specific detection\",\n      \"pmids\": [\"8245032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"ATP2B2 (PMCA2) was localized to human chromosome 3p26→p25 by fluorescence in situ hybridization (FISH), analysis of somatic cell hybrids, and genetic linkage analyses.\",\n      \"method\": \"FISH, somatic cell hybrid analysis, genetic linkage\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal mapping methods\",\n      \"pmids\": [\"8187550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The PMCA2b C-terminal tail interacts with multiple members of the membrane-associated guanylate kinase (MAGUK)/SAP family, including SAP90/PSD95, PSD93/chapsyn-110, and SAP97, but not SAP102, whereas PMCA4b interacts promiscuously with all four SAPs. PMCA2b colocalized with SAP90/PSD95 in hippocampal neuron dendrites and dendritic spines.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, confocal immunofluorescence microscopy in polarized MDCK cells and hippocampal neurons\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP and localization with functional context, multiple methods\",\n      \"pmids\": [\"11274188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PMCA2 is expressed in the P-type ATPase family characterized by formation of an aspartyl-phosphate intermediate during the reaction cycle. Alternative splicing of PMCA2 at the first intracellular loop (site A) and C-terminal tail (site C) generates isoforms with different calmodulin regulation, phospholipid sensitivity, and PDZ-domain protein interactions. The PMCA2w/a splice variant is the major form in hair cell stereocilia.\",\n      \"method\": \"Biochemical characterization, review of splice variant expression and functional differences\",\n      \"journal\": \"Physiological reviews\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — comprehensive review integrating multiple independent biochemical and genetic studies\",\n      \"pmids\": [\"11152753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PMCA2 is localized to hair cell stereocilia in mouse inner ear (demonstrated by immunocytochemistry), where it contributes to maintaining endolymph calcium homeostasis. Deafwaddler2J (dfw2J) mice lacking functional PMCA2 in stereocilia have significantly lower endolymph calcium concentrations compared to controls, linking PMCA2 stereociliary activity to endolymph Ca2+ levels and hearing/balance function.\",\n      \"method\": \"Immunocytochemistry, calcium-sensitive fluorescent dye measurement using aspirating microelectrode in dfw2J vs. control mouse endolymph\",\n      \"journal\": \"Journal of the Association for Research in Otolaryngology : JARO\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with functional consequence measured by calcium assay in loss-of-function model\",\n      \"pmids\": [\"15357414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"A heterozygous, hypofunctional variant (V586M) in PMCA2 (ATP2B2) acts as a modifier of sensorineural hearing loss severity. In siblings homozygous for a CDH23 mutation, those also carrying V586M had more severe hearing loss. V586M was also found in unrelated individuals with increased hearing loss caused by other factors (MYO6 mutation or noise exposure), establishing PMCA2 as a genetic modifier of hearing loss severity.\",\n      \"method\": \"Genetic analysis of human families with SNHL, functional characterization of V586M as hypofunctional variant\",\n      \"journal\": \"The New England journal of medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human genetic epistasis in multiple families with functional variant characterization\",\n      \"pmids\": [\"15829536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Differential membrane targeting of PMCA1 and PMCA2 in hair cells is determined by distinct molecular signals: a Leu-Ile motif in 'b'-tail splice variants promotes basolateral sorting of PMCA1b and PMCA2b, while apical targeting of PMCA2 depends on the size of the A-site splice insert in the first cytosolic loop, suggesting the loop conformation plays a role in apical targeting.\",\n      \"method\": \"Expression of PMCA isoforms and splice variants with mutagenesis in hair cells and cell lines, immunofluorescence targeting assays\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis-guided localization studies in native hair cells identifying specific targeting determinants\",\n      \"pmids\": [\"16803870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PMCA2 co-immunoprecipitates with the metabotropic glutamate receptor 1 (mGluR1), Homer 3, and IP3R1 in the cerebellum, indicating that PMCA2 is a constituent of the mGluR1 signaling complex. In PMCA2-null mice, the levels of mGluR1, IP3R1, Homer 1b/c, and Homer 3 are specifically reduced in Purkinje neurons but not in hippocampus, perturbing the mGluR1 signaling complex and likely contributing to cerebellar deficits.\",\n      \"method\": \"Co-immunoprecipitation, immunohistochemistry, Western blotting in PMCA2-null vs. wild-type mouse cerebellum\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP identifying complex membership, confirmed by loss-of-function phenotype\",\n      \"pmids\": [\"17150372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Atp2b2 expression is regulated through four distinct transcriptional start regions (alpha, beta, mu, delta) with tissue-specific usage. The alpha transcript is dominant in cochlear hair cells and cerebellar Purkinje neurons, while mu and delta are novel variants expressed predominantly in lactating mammary gland. The alpha and beta first-exon regions show high conservation in mammals.\",\n      \"method\": \"5'-RACE, real-time RT-PCR, microdissection of cochlea, in situ hybridization, comparative genomics\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods identifying tissue-specific regulatory mechanisms\",\n      \"pmids\": [\"16675132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The Oblivion (Obl) ENU-induced mouse mutation causes a S877F substitution in transmembrane domain 6 of PMCA2. Unlike other transmembrane domain mutations, the protein is correctly targeted to the plasma membrane, but biochemical and biophysical characterization showed significant loss of non-stimulated Ca2+ exporting ability, explaining progressive hearing loss.\",\n      \"method\": \"ENU mutagenesis, sequencing, immunofluorescence of mutant pump in hair cells, biochemical/biophysical characterization of Ca2+ export in CHO model cells\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — biochemical activity assay and localization of mutant pump with clear phenotypic correlation\",\n      \"pmids\": [\"18974863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The Tommy ENU mutation (E629K in the second intracellular loop/active site) impairs long-term, non-stimulated calcium extrusion activity of PMCA2 in CHO cells. Direct calcium imaging with flash photolysis of caged calcium in neonatal organotypic utricle cultures confirmed impairment of calcium export in both Tommy heterozygotes and homozygotes, establishing that cytosolic calcium clearance in hair cells requires PMCA2 active-site integrity.\",\n      \"method\": \"Ca2+ extrusion assay in CHO cells expressing mutant PMCA2, confocal imaging with flash photolysis of caged Ca2+ in utricle sensory epithelium organotypic cultures\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct functional assay in both heterologous cells and native tissue with well-defined mutant\",\n      \"pmids\": [\"20826782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PMCA2 is the dominant mechanism for Ca2+ clearance in cerebellar Purkinje neuron dendrites. Heterozygous PMCA2 knockout mice expressing half-normal PMCA2 levels showed nearly doubled calcium transient recovery times, weaker climbing fiber responses, prolonged Ca2+-dependent K+ currents, and reduced action potential firing frequency, demonstrating that PMCA2 level directly controls dendritic calcium dynamics and cerebellar motor coordination precision.\",\n      \"method\": \"Calcium imaging in brain slices, whole-cell patch clamp recording, beam-walking motor tests in PMCA2+/- vs. wild-type mice\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean haploinsufficiency model with defined electrophysiological and calcium phenotypes, multiple orthogonal methods\",\n      \"pmids\": [\"20083513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PMCA2 is down-regulated early during mammary gland involution following weaning, and this loss raises intracellular calcium and sensitizes mammary epithelial cells (MECs) to apoptosis. Conversely, overexpression of PMCA2 in T47D breast cancer cells lowers intracellular calcium and protects them from apoptosis, identifying PMCA2 as a calcium extrusion pump that regulates apoptotic threshold in MECs.\",\n      \"method\": \"Western blotting, calcium imaging, apoptosis assays in PMCA2 knockdown/overexpression MECs and T47D cells, mammary gland involution model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss and gain of function with defined calcium and apoptosis readouts\",\n      \"pmids\": [\"20534448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In PMCA2-/- Purkinje neurons, basal calcium levels are elevated, calcium recovery kinetics are severely impaired, membrane potentials are hyperpolarized, spontaneous action potential frequency is reduced and irregular, complex spikes are curtailed, and Ca2+-dependent outward K+ currents are sustained. These electrophysiological changes represent adaptations that limit pathological calcium rises but are insufficient to maintain normal cerebellar output.\",\n      \"method\": \"Whole-cell patch clamp recording and calcium imaging in PMCA2-/- vs. wild-type Purkinje neurons\",\n      \"journal\": \"Functional neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct electrophysiological and calcium measurements in knockout Purkinje neurons\",\n      \"pmids\": [\"21232211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Analysis of the human PMCA2 V586M mutant (associated with modified hearing loss in patients) and a murine mutant in model cells revealed that the human mutant does not impair Ca2+ ejection by the pump, whereas the murine mutant shows defects in both basal pump activity and long-range Ca2+ ejection. The PMCA2w/a splice variant can eject Ca2+ to the endolymph even in the absence of calmodulin, satisfying the special Ca2+ homeostasis requirements of stereocilia.\",\n      \"method\": \"Expression of mutant PMCA2 in model cells, Ca2+ ejection assays, comparison of human and murine mutants\",\n      \"journal\": \"Cell calcium\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro Ca2+ extrusion assay with defined mutants and calmodulin-independence characterization\",\n      \"pmids\": [\"22047666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PMCA2 inhibits the calcineurin/NFAT signaling pathway in breast cancer cells through a direct inhibitory interaction with calcineurin. Disruption of the PMCA2/calcineurin interaction activates calcineurin/NFAT signaling, upregulates pro-apoptotic Fas Ligand expression, reduces cell viability through increased apoptosis, and enhances paclitaxel-mediated cytotoxicity.\",\n      \"method\": \"Co-immunoprecipitation, calcineurin/NFAT pathway activation assays, Fas Ligand expression, apoptosis assays, viability assays in multiple breast cancer cell lines\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus functional pathway activation and apoptosis readouts in multiple cell lines\",\n      \"pmids\": [\"22962307\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PMCA2 is associated with α7-nicotinic acetylcholine receptors (α7-nAChRs) in rat brain via the scaffold protein PSD-95. PMCA2 activity limits the duration of calcium elevations produced by α7-nAChR activation in hippocampal interneurons. PMCA2 inhibition triggers rapid, CaMKII- and proteasome-dependent loss of α7-nAChR clusters through a mechanism that requires PSD-95 linkage and depends on the second intracellular loop of the α7 subunit.\",\n      \"method\": \"Functional proteomics on rat brain, co-immunoprecipitation, calcium imaging, single-particle tracking, pharmacological inhibition, siRNA knockdown in hippocampal interneuron cultures\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional proteomics, co-IP, live-cell calcium imaging, and single-particle tracking with multiple orthogonal methods\",\n      \"pmids\": [\"22593058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The alternatively spliced w-insert of PMCA2 provides autonomous apical targeting information. When inserted into the corresponding location of the normally basolateral PMCA4 isoform, it confers apical membrane targeting. Optimizing the PDZ ligand at the C-terminus for NHERF2 interaction further enhanced apical targeting. Both apical and basolateral pump configurations handled ATP-induced Ca2+ signals with similar kinetics, indicating the targeting signal does not alter intrinsic pump function.\",\n      \"method\": \"Chimeric PMCA4(2w)/b construct expression in polarized epithelial cells, immunofluorescence localization, Ca2+ signaling assays, mutagenesis of di-leucine and PDZ ligand motifs\",\n      \"journal\": \"Cell calcium\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — chimeric construct mutagenesis with localization and functional assays identifying autonomous targeting signal\",\n      \"pmids\": [\"22252018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PMCA2 knockdown in PC12 cells accelerates neuronal differentiation and formation of longer neurites. Loss of PMCA2 triggers apoptosis and DNA laddering during differentiation, accompanied by compensatory upregulation of PMCA1, PMCA4, and SERCA, as well as altered expression of voltage-dependent calcium channels (VDCCs) with increased contribution to Ca2+ influx.\",\n      \"method\": \"Antisense-mediated stable knockdown in PC12 cells, differentiation assays with dibutyryl-cAMP, apoptosis/DNA laddering assays, immunoblotting for calcium handling proteins, functional VDCC assays\",\n      \"journal\": \"Cell calcium\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — loss-of-function with defined cellular phenotypes, single lab\",\n      \"pmids\": [\"22921123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PMCA2 activity is required for maintaining dendritic calcium equilibrium and controlling Purkinje cell dendritic growth in organotypic cerebellar slice cultures. Pharmacological inhibition of PMCA2 with carboxyeosin moderately reduced Purkinje cell dendritic tree size. Combining PMCA2 inhibition with type I mGluR stimulation partially rescued dendritic morphology by triggering compensatory inactivation of voltage-gated calcium channels.\",\n      \"method\": \"Carboxyeosin pharmacological inhibition of PMCA2 activity in organotypic cerebellar slice cultures, immunofluorescence, dendritic morphometry\",\n      \"journal\": \"Neural plasticity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — pharmacological inhibition with morphological readout, single lab\",\n      \"pmids\": [\"24288624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PMCA2 downregulation by MPP+ (mitochondrial complex I inhibitor) in SH-SY5Y neuroblastoma cells and primary mesencephalic neurons leads to elevated cytosolic calcium and increased neuronal vulnerability. Two other Ca2+ efflux mediators (SERCA, NCX) were unaffected, indicating PMCA2-specific role in neuronal calcium homeostasis. siRNA knockdown of PMCA2 impaired cell survival, while PMCA2 overexpression conferred resistance to complex I inhibition.\",\n      \"method\": \"MPP+ treatment, Western blotting, calcium imaging, siRNA knockdown and overexpression in SH-SY5Y and primary mesencephalic neurons\",\n      \"journal\": \"Neurotoxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — loss and gain of function with calcium and viability readouts, single lab\",\n      \"pmids\": [\"24269647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PMCA2 interacts with HER2 in actin-rich membrane domains in breast cancer cells. Knocking down PMCA2 raises intracellular calcium, disrupts interactions between HER2 and HSP-90, inhibits HER2 signaling, and causes internalization and degradation of HER2. PMCA2 knockout inhibits mammary tumor formation in MMTV-Neu mice, demonstrating that PMCA2 is required for HER2 membrane retention, stability, and oncogenic signaling.\",\n      \"method\": \"Co-immunoprecipitation, PMCA2 knockdown and knockout, HER2 signaling assays, subcellular fractionation, intracellular calcium measurement, in vivo MMTV-Neu tumor model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP, multiple loss-of-function approaches, in vivo tumor model, multiple orthogonal methods\",\n      \"pmids\": [\"26729871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Disrupting the actin cytoskeleton with cytochalasin D significantly increases PMCA2-mediated Ca2+ extrusion (~50-100%) in living HEK293 cells, while stabilizing F-actin with jasplakinolide fully inhibits it. Disrupting microtubules with colchicine decreases PMCA activity (~40-60%). These effects occur without changing surface expression levels, indicating regulation of specific activity.\",\n      \"method\": \"Real-time cytosolic calcium monitoring in PMCA2-transfected HEK293 cells treated with cytoskeletal drugs, surface biotinylation assays\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assay in living cells with pharmacological perturbation of cytoskeleton, surface expression controls\",\n      \"pmids\": [\"28527708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PMCA2-interacting complex in kidney cells was characterized by immunoprecipitation followed by nanoLC-ESI mass spectrometry, identifying 474 PMCA2-interacting proteins (8 known, 20 predicted, 446 novel). A novel functional role of PMCA2 as a calcium oxalate monohydrate (COM) crystal-binding protein was identified and validated, showing that PMCA2 is required for crystal retention and cellular uptake in kidney cells.\",\n      \"method\": \"Immunoprecipitation-mass spectrometry, quantitative immuno-co-localization, COM crystal-protein binding assay, crystal-cell adhesion assay, crystal internalization assay, anti-PMCA2 antibody neutralization\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — proteomics interactome with functional validation by neutralization antibody\",\n      \"pmids\": [\"29085954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PMCA2 is required for estrogen receptor alpha (ERα) signaling in the female dorsal horn of the spinal cord. Female PMCA2+/- mice show increased mechanical pain sensitivity (52%) and reduced heat sensitivity (29%), while males do not. Intrathecal ERα agonist fails to activate ERα signaling in female PMCA2+/- mice but is effective in PMCA2+/+ females, establishing a female-specific link between PMCA2, ERα signaling, and pain modulation.\",\n      \"method\": \"Behavioral pain assays (von Frey, Hargreaves), ovariectomy/hormone replacement, intrathecal drug administration, western blotting of dorsal horn signaling proteins in PMCA2+/- vs +/+ mice\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — clean haploinsufficiency model with behavioral and molecular readouts, single lab\",\n      \"pmids\": [\"30467368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PMCA2w/a splice variant in hair cell stereocilia increases its activity only marginally in response to rapid cytoplasmic Ca2+ elevation (unlike other PMCA2 variants which are strongly stimulated), enabling sustained calcium extrusion independent of calmodulin activation. Missense mutations of PMCA2w/a that cause deafness correlate with defects in homeostatic regulation of stereociliary Ca2+, decreased mechanotransduction channel sensitivity, and progressive organ of Corti degeneration.\",\n      \"method\": \"Biophysical and biochemical characterization of PMCA2w/a splice variant, mouse genetic models with functional hearing and calcium assays\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical characterization of splice-variant-specific functional property with multiple supporting mouse models\",\n      \"pmids\": [\"29452611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NHERF1 interacts with PMCA2 at the apical membrane of secretory luminal epithelial cells during lactation and is required for proper apical localization of PMCA2. NHERF1 knockout disrupts PMCA2 apical targeting, impairs apical-basal polarity, and leads to premature Stat3 activation and lysosome-mediated mammary epithelial cell death. PMCA2 also interacts with the closely related NHERF2 at the apical membrane.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence localization, NHERF1 knockout mice, Western blotting for Stat3 activation, lactation and involution phenotype analysis\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP, knockout model with localization and signaling phenotypes, multiple orthogonal methods\",\n      \"pmids\": [\"31087002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Decreased PMCA2 expression in the dorsal horn is paralleled by increased neuropathic pain in EAE (MS model) and spinal cord injury mice. In pure spinal cord neuronal cultures, IL-1β directly downregulates PMCA2 levels, acting as an effector that reduces neuronal PMCA2 expression and thereby perturbs calcium signaling contributing to pain sensitization.\",\n      \"method\": \"EAE and SCI mouse models, behavioral pain testing, Western blotting of dorsal horn PMCA2, cytokine profiling, pure SC neuronal culture treatment with IL-1β, TNFα, IL-6\",\n      \"journal\": \"Journal of neuroinflammation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — in vivo and in vitro correlated data, direct neuronal treatment identifies specific effector\",\n      \"pmids\": [\"31703709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"De novo ATP2B2 missense variants affecting evolutionarily conserved sites, and frameshift variants in the penultimate exon, cause a neurodevelopmental syndrome with ataxia, dystonia, intellectual disability, autism, and seizures. Cell-based functional studies showed that all variants caused significant alterations in cytosolic calcium handling with both loss- and gain-of-function effects, establishing that precise PMCA2-mediated calcium regulation is essential for neurodevelopment and cerebellar function.\",\n      \"method\": \"Exome/genome sequencing, trio-based genomics, in silico analyses, cell-based cytosolic calcium handling assays\",\n      \"journal\": \"Genetics in medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional calcium assays in cells for each variant combined with human genetic evidence, multiple variants tested\",\n      \"pmids\": [\"37675773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A splice variant-dependent localization of PMCA2 to the lysosome was discovered. Lysosomal PMCA2 forms an evolutionarily conserved complex with NPC1 (the lysosomal membrane protein defective in Niemann-Pick disease type C). This lysosomal PMCA2-NPC1 interaction is involved in maintaining lysosomal calcium levels, and its disruption contributes to the pathophysiology of both NPC disease and Parkinson's disease, revealing a previously unrecognized intracellular role for PMCA2 in lysosomal calcium and lipid regulation.\",\n      \"method\": \"Splice variant localization studies, co-immunoprecipitation/complex identification with NPC1, lysosomal calcium measurements, disease models (NPC, Parkinson's)\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — novel localization discovery with complex identification and functional consequence, preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.10.01.679724\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ATP2B2 exhibits marked expression deficits at the synaptic proteome level in dorsolateral prefrontal cortex of individuals with schizophrenia. Structural analysis using AlphaFold3 models identified an enrichment of neuropsychiatric disease-associated deleterious missense variants in close spatial proximity to both the Ca2+ permeation tunnel and the ATP:Mg2+ coordination site. Cellular and biochemical analyses of canonical Ca2+-binding site variants confirmed clear loss-of-function effects on Ca2+ extrusion, linking genetic variants to impaired Ca2+ homeostasis in excitatory neurons.\",\n      \"method\": \"Single-nucleus RNA-seq, synaptic proteomics, AlphaFold3 structural modeling, case-control missense variant analysis, cellular/biochemical Ca2+ extrusion assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — structural modeling plus biochemical functional validation, preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.08.25.672202\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Exosomal PIP (prolactin-induced protein) from atrial fibrillation patients suppresses ATP2B2 expression, thereby inhibiting the cGMP/PKG signaling pathway and promoting myocardial fibrosis. ATP2B2 overexpression reversed the pro-fibrotic effects of PIP on cardiac fibroblasts and endothelial cells, while AAV-shPIP reduced AF incidence in rats. Activation of cGMP/PKG is beneficial for alleviating fibrosis, but this is mitigated by ATP2B2 knockdown.\",\n      \"method\": \"Exosome characterization, shRNA knockdown and overexpression of PIP and ATP2B2, CF and HUVEC functional assays, AAV-mediated shPIP in rat AF model, cGMP/PKG pathway analysis\",\n      \"journal\": \"Antioxidants & redox signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain and loss of function with pathway analysis in cells and in vivo rat model, single lab\",\n      \"pmids\": [\"40094760\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ATP2B2/PMCA2 is a P-type Ca2+-ATPase that extrudes Ca2+ from the cytosol at the plasma membrane (primarily as the w/a splice variant in hair cell stereocilia), maintaining Ca2+ homeostasis in inner ear hair cells, cerebellar Purkinje neurons, and mammary epithelial cells; its activity is regulated by alternative splicing (governing calmodulin sensitivity, PDZ interactions, and subcellular targeting to apical vs. basolateral membranes), cortical cytoskeletal dynamics, and interactions with scaffold proteins (NHERF1/2, PSD-95), and it participates in multi-protein signaling complexes with mGluR1/Homer/IP3R1, HER2/HSP90, calcineurin/NFAT, and α7-nAChR/PSD-95 to regulate local calcium signaling and downstream apoptotic, proliferative, and synaptic processes; a lysosome-targeted splice variant additionally forms a complex with NPC1 to regulate lysosomal Ca2+ and lipid homeostasis relevant to neurodegeneration.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ATP2B2 encodes PMCA2, a plasma membrane Ca²⁺-ATPase that serves as the principal calcium extrusion pump in auditory hair cell stereocilia, cerebellar Purkinje neuron dendrites, and lactating mammary epithelium, where it governs cytosolic calcium clearance kinetics critical for sensory transduction, neuronal firing, and milk calcium secretion [PMID:15357414, PMID:20083513, PMID:20534448]. Alternative splicing at the A-site generates a w-insert that confers constitutively high, calmodulin-independent basal pump activity and autonomous apical membrane targeting, while PDZ-ligand interactions with NHERF1/2 further stabilize apical localization in polarized epithelia [PMID:22047666, PMID:22252018, PMID:31087002]. Beyond ion transport, PMCA2 organizes signaling complexes—associating with mGluR1/Homer/IP3R1 in Purkinje neurons, α7-nAChR/PSD-95 in hippocampal interneurons, HER2/HSP90 in breast epithelium, and calcineurin/NFAT in cancer cells—thereby coupling local calcium homeostasis to downstream signaling cascades [PMID:17150372, PMID:22593058, PMID:26729871, PMID:22962307]. De novo missense and frameshift variants in ATP2B2 cause a spectrum of neurodevelopmental disorders including ataxia, dystonia, intellectual disability, and seizures, and hypofunctional variants modify the severity of hereditary sensorineural hearing loss [PMID:37675773, PMID:15829536].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Identification of ATP2B2 as a distinct PMCA isoform established that mammals possess multiple plasma membrane calcium pumps with potential tissue-specific roles.\",\n      \"evidence\": \"cDNA cloning and sequencing of human and rat PMCA2 with chromosomal mapping via somatic cell hybrids\",\n      \"pmids\": [\"1427863\", \"8187550\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No tissue expression profiling performed\", \"Functional distinction from PMCA1/3/4 not yet characterized\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrating that PMCA2 localizes to stereocilia and is the principal source of endolymph calcium resolved how the cochlea maintains its uniquely low-calcium extracellular environment essential for mechanotransduction.\",\n      \"evidence\": \"Immunocytochemistry in hair cells and endolymph calcium measurement in deafwaddler2J knockout mice\",\n      \"pmids\": [\"15357414\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of other calcium transporters to endolymph calcium not quantified\", \"Mechanism of PMCA2 enrichment at stereocilia tips not defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identifying ATP2B2 V586M as a genetic modifier of hearing loss caused by CDH23 or MYO6 mutations established that PMCA2 pump capacity is a quantitative determinant of auditory function across diverse genetic backgrounds.\",\n      \"evidence\": \"Human family genetic analysis with functional characterization of V586M variant\",\n      \"pmids\": [\"15829536\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Population frequency and penetrance of modifier effect not fully determined\", \"Biochemical mechanism of V586M impairment not resolved at this stage\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Mapping the w-insert as an autonomous apical targeting signal and demonstrating tissue-specific promoter usage explained how a single gene directs PMCA2 to stereocilia in hair cells, Purkinje dendrites, and mammary apical membranes through combinatorial transcriptional and splicing control.\",\n      \"evidence\": \"Chimeric constructs and immunofluorescence in polarized cells; 5'-RACE and RT-PCR across tissues\",\n      \"pmids\": [\"16803870\", \"16675132\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trans-acting factors recognizing the w-insert for apical sorting not identified\", \"Regulatory elements driving tissue-specific promoter choice not mapped\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"The discovery that PMCA2 co-immunoprecipitates with mGluR1, Homer3, and IP3R1 in Purkinje neurons—and that its loss destabilizes these partners—revealed PMCA2 as a structural organizer of metabotropic glutamate signaling complexes, not merely a calcium pump.\",\n      \"evidence\": \"Co-immunoprecipitation and Western blotting in PMCA2-null mouse cerebellum\",\n      \"pmids\": [\"17150372\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding interface between PMCA2 and mGluR1 complex not mapped\", \"Whether scaffold function is calcium-dependent or independent not tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Characterization of ENU-induced pump-dead mutants (Oblivion S877F and Tommy E629K) separated transport-competent targeting from basal pump activity, showing that even modest reductions in non-stimulated calcium extrusion cause progressive hair cell degeneration.\",\n      \"evidence\": \"ENU mutagenesis with in vitro calcium extrusion assays and in vivo hair cell imaging\",\n      \"pmids\": [\"18974863\", \"20826782\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for how these mutations impair pump cycling not resolved\", \"Threshold of pump activity below which hair cells degenerate not quantified\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showing that 50% reduction of PMCA2 nearly doubles dendritic calcium transient recovery time and impairs motor coordination established PMCA2 as the rate-limiting calcium clearance mechanism in Purkinje neurons, linking pump dosage directly to cerebellar circuit function.\",\n      \"evidence\": \"Two-photon calcium imaging, patch clamp, and behavioral beam-walking in PMCA2+/- mice\",\n      \"pmids\": [\"20083513\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of other clearance mechanisms (NCX, SERCA, mitochondria) in Purkinje cells not simultaneously quantified\", \"Impact on synaptic plasticity (LTD) not assessed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Bidirectional manipulation of PMCA2 in mammary cells proved that the pump directly controls intracellular calcium levels that gate apoptosis during involution, establishing a non-neuronal survival function for PMCA2.\",\n      \"evidence\": \"Knockdown and overexpression in mammary/breast cancer cells with calcium and apoptosis readouts\",\n      \"pmids\": [\"20534448\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the calcium-sensitive apoptotic effector downstream of PMCA2 not fully defined\", \"Whether PMCA2 anti-apoptotic role operates in non-mammary epithelia not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Reconstitution of PMCA2w/a pump activity demonstrated that the w/a splice variant possesses constitutively high basal activity independent of calmodulin, explaining why stereocilia—lacking calmodulin-mediated activation—rely on this specific isoform.\",\n      \"evidence\": \"Overexpression of wild-type and mutant PMCA2w/a in model cells with calcium extrusion assays\",\n      \"pmids\": [\"22047666\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural mechanism by which the w-insert bypasses calmodulin requirement not determined\", \"Whether w/a retains calmodulin sensitivity for further activation not clarified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Discovery that PMCA2 associates with α7-nAChR/PSD-95 and with calcineurin/NFAT in distinct cell types expanded the signaling-complex organizer paradigm beyond the cerebellum, showing that local calcium domains shaped by PMCA2 gate receptor stability and transcriptional programs.\",\n      \"evidence\": \"Functional proteomics and single-particle tracking in hippocampal interneurons; Co-IP and NFAT/FasL assays in breast cancer cells\",\n      \"pmids\": [\"22593058\", \"22962307\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and direct vs. scaffolded nature of PMCA2–α7-nAChR interaction not resolved\", \"Whether calcineurin binding is specific to PMCA2 or shared with other PMCA isoforms not tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Establishing that PMCA2 maintains HER2 signaling by stabilizing HER2–HSP90 complexes at the membrane—and that PMCA2 knockout suppresses mammary tumorigenesis in MMTV-Neu mice—identified PMCA2 as a druggable node in HER2-positive breast cancer.\",\n      \"evidence\": \"Co-IP, knockdown/knockout, HER2 signaling and degradation assays, MMTV-Neu tumor model\",\n      \"pmids\": [\"26729871\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding interface between PMCA2 and HER2 not mapped\", \"Whether PMCA2 inhibition can synergize with anti-HER2 therapies in human tumors not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrating that NHERF1 is required for PMCA2 apical retention in mammary epithelium—and that its loss triggers premature involution via Stat3—connected calcium pump localization to epithelial polarity and tissue remodeling programs.\",\n      \"evidence\": \"Co-IP and NHERF1 knockout mouse with PMCA2 mislocalization, polarity disruption, and Stat3 phosphorylation\",\n      \"pmids\": [\"31087002\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NHERF2 can compensate for NHERF1 loss in vivo not determined\", \"Mechanism linking calcium dyshomeostasis to Stat3 activation not defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of de novo ATP2B2 variants causing neurodevelopmental disorders with both loss- and gain-of-function calcium handling effects established ATP2B2 as a bona fide disease gene for ataxia, dystonia, intellectual disability, and seizures, broadening its clinical relevance beyond hearing loss.\",\n      \"evidence\": \"Trio exome/genome sequencing in multinational cohort with cell-based calcium assays for each variant\",\n      \"pmids\": [\"37675773\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genotype–phenotype correlation for gain- vs. loss-of-function variants not fully delineated\", \"Circuit-level consequence of each variant class in the brain not modeled\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Whether the recently reported lysosomal PMCA2 splice variant–NPC1 complex represents a physiologically significant calcium efflux pathway at lysosomes, and whether PMCA2 gain-of-function and loss-of-function disease variants require distinct therapeutic strategies, remain open questions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Lysosomal PMCA2–NPC1 finding is from a single preprint and awaits peer review and independent confirmation\", \"No structural model of PMCA2 in any splice form exists at atomic resolution\", \"Therapeutic targeting strategy for PMCA2-related neurodevelopmental disease not explored\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 7, 9, 11]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 2, 7, 9, 11]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [5, 12, 15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 2, 4, 7, 14, 15]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"GO:0005929\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 2, 7, 9, 11]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 13, 15]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [8, 13]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [5, 10, 12]}\n    ],\n    \"complexes\": [\n      \"mGluR1/Homer/IP3R1 complex\",\n      \"α7-nAChR/PSD-95 complex\",\n      \"HER2/HSP90 complex\"\n    ],\n    \"partners\": [\n      \"GRM1\",\n      \"HOMER3\",\n      \"ITPR1\",\n      \"ERBB2\",\n      \"HSP90AA1\",\n      \"SLC9A3R1\",\n      \"SLC9A3R2\",\n      \"PPP3CA\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"ATP2B2 encodes PMCA2, a P-type Ca²⁺-ATPase that actively extrudes cytosolic calcium across the plasma membrane, functioning as the dominant calcium clearance mechanism in inner ear hair cell stereocilia and cerebellar Purkinje neuron dendrites [PMID:5357414, PMID:20083513]. Alternative splicing at the first intracellular loop (site A) and C-terminal tail (site C) generates isoforms with distinct calmodulin sensitivity, apical versus basolateral membrane targeting, and PDZ-domain scaffold interactions (NHERF1/2, PSD-95), with the w/a splice variant providing calmodulin-independent sustained Ca²⁺ extrusion in stereocilia [PMID:8245032, PMID:22252018, PMID:29452611, PMID:31087002]. PMCA2 participates in multi-protein signaling complexes—including mGluR1/Homer/IP3R1 in cerebellum, α7-nAChR/PSD-95 in hippocampus, and HER2/HSP90 in breast cancer cells—through which it couples local calcium homeostasis to synaptic function, receptor stability, calcineurin/NFAT-mediated apoptosis, and mammary gland involution [PMID:17150372, PMID:22593058, PMID:26729871, PMID:22962307, PMID:20534448]. De novo ATP2B2 missense and frameshift variants cause a neurodevelopmental syndrome featuring ataxia, dystonia, intellectual disability, and seizures, while hypofunctional variants modify sensorineural hearing loss severity [PMID:37675773, PMID:15829536].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Molecular identity of PMCA2 was established by cloning the human ATP2B2 cDNA, revealing it as a distinct plasma membrane Ca²⁺-ATPase isoform with high interspecies conservation and mapping it to chromosome 3.\",\n      \"evidence\": \"cDNA cloning, sequencing, and somatic cell hybrid Southern blot analysis\",\n      \"pmids\": [\"1427863\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional characterization of pump activity at this stage\", \"Tissue-specific expression pattern not yet determined\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Alternative splicing at two regulatory sites (A and C) was shown to generate multiple PMCA2 isoforms with tissue-restricted expression (brain, skeletal muscle), establishing that splice variation is a major determinant of PMCA2 functional diversity.\",\n      \"evidence\": \"Quantitative RT-PCR with isoform-specific primers across seven human tissues\",\n      \"pmids\": [\"8245032\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequences of individual splice variants not yet measured\", \"Subcellular targeting determinants of splice variants unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"PMCA2b was found to interact selectively with PDZ-domain scaffold proteins (PSD-95, PSD-93, SAP97 but not SAP102) and colocalize with PSD-95 in hippocampal dendritic spines, establishing PMCA2 as a component of organized postsynaptic signaling complexes rather than an isolated pump.\",\n      \"evidence\": \"Yeast two-hybrid, co-immunoprecipitation, confocal immunofluorescence in MDCK cells and hippocampal neurons\",\n      \"pmids\": [\"11274188\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of PMCA2–scaffold interaction on local calcium dynamics not yet measured\", \"Selectivity mechanism for SAP family members unclear\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"PMCA2 was localized to hair cell stereocilia and shown to be essential for endolymph calcium homeostasis: deafwaddler2J mice lacking stereociliary PMCA2 had significantly reduced endolymph Ca²⁺, directly linking pump activity to hearing and balance.\",\n      \"evidence\": \"Immunocytochemistry and Ca²⁺-sensitive fluorescent dye measurement in dfw2J versus control mouse endolymph\",\n      \"pmids\": [\"15357414\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of PMCA2 relative to other Ca²⁺ transport mechanisms in endolymph not quantified\", \"Mechanism of progressive hair cell degeneration not delineated\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"The first human genetic evidence showed that a hypofunctional PMCA2 variant (V586M) acts as a modifier of sensorineural hearing loss severity across multiple families and etiologies, establishing PMCA2 as a clinically relevant modifier locus.\",\n      \"evidence\": \"Genetic analysis of human families with SNHL, functional characterization of V586M\",\n      \"pmids\": [\"15829536\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise biochemical defect of V586M debated—later studies showed it may not impair Ca²⁺ ejection directly\", \"Population frequency and penetrance not fully defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Splice-dependent membrane targeting was mechanistically resolved: the w-insert in the first intracellular loop drives apical targeting, while a Leu-Ile motif in the b-tail promotes basolateral sorting, explaining how the same gene achieves polarized distribution in different cell types.\",\n      \"evidence\": \"PMCA chimera mutagenesis and immunofluorescence targeting assays in hair cells and cell lines\",\n      \"pmids\": [\"16803870\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding partners that read the w-insert apical signal not identified\", \"Whether targeting mechanism is identical in hair cells versus epithelial cells not resolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"PMCA2 was identified as a constituent of the mGluR1/Homer/IP3R1 signaling complex in cerebellum: PMCA2-null mice showed reduced levels of multiple complex members specifically in Purkinje neurons, revealing that PMCA2 is structurally required for complex integrity.\",\n      \"evidence\": \"Co-immunoprecipitation and immunohistochemistry in PMCA2-null versus wild-type mouse cerebellum\",\n      \"pmids\": [\"17150372\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding interface between PMCA2 and mGluR1 not mapped\", \"Whether complex disruption is cause or consequence of Purkinje neuron dysfunction not fully dissected\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The Oblivion (S877F) mutation demonstrated that a transmembrane domain substitution can abolish non-stimulated Ca²⁺ export while preserving correct plasma membrane targeting, dissecting pump activity from trafficking for the first time.\",\n      \"evidence\": \"ENU mutagenesis, immunofluorescence, biochemical/biophysical Ca²⁺ export assays in CHO cells expressing mutant PMCA2\",\n      \"pmids\": [\"18974863\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for selective loss of basal versus stimulated activity not resolved\", \"Whether similar mechanism applies to human hearing loss mutations unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Haploinsufficiency studies in heterozygous PMCA2 knockout mice established that PMCA2 is the rate-limiting calcium clearance mechanism in Purkinje dendrites: half-normal levels nearly doubled Ca²⁺ transient recovery time and degraded cerebellar motor output, while complete knockout showed elevated basal Ca²⁺, hyperpolarized membranes, and aberrant firing.\",\n      \"evidence\": \"Calcium imaging and whole-cell patch clamp in brain slices from PMCA2+/− and PMCA2−/− mice, beam-walking behavioral tests\",\n      \"pmids\": [\"20083513\", \"21232211\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of compensatory mechanisms (SERCA, NCX) in knockout not fully quantified\", \"Long-term neurodegenerative consequences not tracked\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"PMCA2 was shown to regulate apoptotic threshold in mammary epithelial cells: its downregulation during involution raises intracellular Ca²⁺ and sensitizes cells to apoptosis, while overexpression in breast cancer cells confers apoptosis resistance, revealing an oncologically relevant survival function.\",\n      \"evidence\": \"PMCA2 knockdown and overexpression in MECs and T47D breast cancer cells, calcium imaging, apoptosis assays, mammary gland involution model\",\n      \"pmids\": [\"20534448\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional regulation of PMCA2 during involution not identified\", \"Interaction with specific apoptotic effectors not mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Two parallel studies revealed that PMCA2 couples its Ca²⁺ extrusion activity to signaling complex regulation: it directly inhibits calcineurin/NFAT to suppress Fas Ligand-mediated apoptosis in breast cancer cells, and it constrains α7-nAChR-evoked calcium transients via PSD-95 scaffolding in hippocampal interneurons, with PMCA2 inhibition triggering CaMKII/proteasome-dependent receptor cluster loss.\",\n      \"evidence\": \"Co-immunoprecipitation, NFAT pathway and apoptosis assays in breast cancer cells; functional proteomics, calcium imaging, and single-particle tracking in hippocampal interneurons\",\n      \"pmids\": [\"22962307\", \"22593058\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Calcineurin binding site on PMCA2 not mapped\", \"Whether α7-nAChR cluster regulation occurs in vivo not tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Chimeric pump experiments proved that the w-insert carries autonomous apical targeting information transferable to the normally basolateral PMCA4, and that NHERF2 PDZ-ligand optimization further enhances apical localization without altering intrinsic pump kinetics.\",\n      \"evidence\": \"Chimeric PMCA4(2w)/b constructs with mutagenesis in polarized epithelial cells, immunofluorescence, Ca²⁺ signaling assays\",\n      \"pmids\": [\"22252018\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the w-insert interacts with specific coat or motor proteins for apical sorting unknown\", \"In vivo validation in hair cells not performed with chimeric constructs\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"PMCA2 was found to interact with HER2 in actin-rich membrane domains and be required for HER2 membrane retention, HSP90 association, and downstream oncogenic signaling; PMCA2 knockout inhibited mammary tumor formation in MMTV-Neu mice, establishing PMCA2 as a functional partner in HER2-driven oncogenesis.\",\n      \"evidence\": \"Co-immunoprecipitation, PMCA2 knockdown/knockout, HER2 signaling and membrane localization assays, MMTV-Neu in vivo tumor model\",\n      \"pmids\": [\"26729871\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct versus calcium-mediated mechanism of HER2 stabilization not fully resolved\", \"Therapeutic targetability of PMCA2–HER2 axis not explored\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Cortical actin dynamics were identified as a direct modulator of PMCA2 specific activity: actin disruption enhanced and actin stabilization abolished Ca²⁺ extrusion without altering surface expression, indicating cytoskeletal gating of pump function.\",\n      \"evidence\": \"Real-time Ca²⁺ monitoring in PMCA2-transfected HEK293 cells treated with cytochalasin D and jasplakinolide, surface biotinylation\",\n      \"pmids\": [\"28527708\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether actin contacts the pump directly or via intermediary proteins unknown\", \"Relevance to native stereociliary or dendritic actin dynamics not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Biophysical characterization showed that the PMCA2w/a splice variant uniquely provides sustained, calmodulin-independent Ca²⁺ extrusion with minimal activity modulation by rapid Ca²⁺ rises—a property essential for stereociliary calcium homeostasis—and that deafness-causing mutations specifically disrupt this homeostatic mode.\",\n      \"evidence\": \"Biochemical and biophysical characterization of PMCA2w/a, mouse genetic models with functional hearing and calcium assays\",\n      \"pmids\": [\"29452611\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for calmodulin-independent activity of w/a variant not resolved\", \"Whether other tissues exploit this constitutive extrusion mode unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"NHERF1 was shown to be required for apical PMCA2 localization in lactating mammary epithelium; its loss mislocalized PMCA2, disrupted polarity, and triggered premature Stat3 activation and lysosome-mediated cell death, linking PMCA2 apical scaffolding to epithelial survival.\",\n      \"evidence\": \"Co-immunoprecipitation, NHERF1 knockout mice, immunofluorescence, Stat3 activation and lactation phenotype analysis\",\n      \"pmids\": [\"31087002\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NHERF2 can compensate for NHERF1 loss not tested\", \"Mechanism linking PMCA2 mislocalization to Stat3 activation not delineated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"De novo ATP2B2 missense and frameshift variants were shown to cause a novel neurodevelopmental syndrome (ataxia, dystonia, intellectual disability, seizures) with both loss- and gain-of-function calcium handling defects, establishing that bidirectional disruption of PMCA2-mediated calcium homeostasis impairs neurodevelopment.\",\n      \"evidence\": \"Exome/genome sequencing in multiple families, trio-based analysis, cell-based cytosolic calcium handling assays for each variant\",\n      \"pmids\": [\"37675773\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Neurodevelopmental cellular mechanisms not elucidated\", \"Genotype-phenotype correlation for gain- versus loss-of-function variants not fully established\", \"No animal model recapitulating the full syndrome\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for calmodulin-independent activity of the w/a splice variant, the identity of apical sorting machinery that reads the w-insert signal, the direct versus calcium-mediated mechanism of HER2 stabilization, and the in vivo significance of lysosomal PMCA2–NPC1 complexes for neurodegeneration.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of full-length PMCA2 in any splice form\", \"Mechanism by which w-insert directs apical sorting unknown\", \"Lysosomal PMCA2–NPC1 complex reported only in preprint\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 4, 10, 11, 15, 26]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [5, 10, 11, 12, 15, 26]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 5, 7, 10, 18, 22, 27]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [22, 23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 4, 5, 10, 11, 12, 15, 26]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8, 16, 17, 22]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [13, 16]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [3, 8, 12, 14, 17]},\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [5, 6, 26]}\n    ],\n    \"complexes\": [\n      \"mGluR1/Homer/IP3R1/PMCA2 complex\",\n      \"α7-nAChR/PSD-95/PMCA2 complex\",\n      \"PMCA2/HER2/HSP90 complex\"\n    ],\n    \"partners\": [\n      \"DLG4\",\n      \"SLC9A3R1\",\n      \"SLC9A3R2\",\n      \"GRM1\",\n      \"HOMER3\",\n      \"ITPR1\",\n      \"ERBB2\",\n      \"PPP3CA\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}